Program Book

SEPTEMBER 7–92006

northeastern Section of the AUA Scientiﬁc PROGRA M

2 Astellas Product Ad Cover 2 TABLE OF CONTENTS

Schedule at a Glance ...... 1-3 Ofﬁcers and Committee Lists ...... 4 Supporter Recognition...... 5 Research and Education Fund ...... 6-7 George E. Slotkin Lecturers...... 8 Guest Speakers ...... 9–13 Publication of Abstracts ...... 14 Program ...... 15 –25 Nursing Program ...... 26 Social Event Info: Dine Around...... 27–28 Social Event Info: Tours...... 29–30 Social Event Info: Events ...... 31–33 Exhibitor Listing (alpha) ...... 34–38 Exhibitor Listing (by Booth Number) ...... 39 Disclosure Information ...... 40–41 CME Form...... 42

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ CONTINUING MEDICAL EDUCATION Accreditation Educational Goals and Objectives The American Urological Association Education and Research, Inc. is The Annual Meeting of the Northeastern Section of the American accredited by the Accreditation Council for Continuing Medical Education Urological Association, Inc. is designed to provide a forum for communi- (ACCME) to provide continuing medical education for physicians. The cating to the members and guest physicians the developing state of the American Urological Association Education and Research, Inc. takes art of science of urological techniques, evaluations and procedures. The responsibility for the content, quality and scientific integrity of this CME program will include original papers presenting new information address- activity. ing pertinent clinical topics. Panel discussion and point-counterpoint sessions on topical issues allow for participants to openly discuss procedure CME Credits and techniques. Participants will have the opportunity to discuss presentations and address questions to authors. At the completion of the The American Urological Association Education and Research, Inc. desig- Annual Meeting, participants should be able to apply this new informa- nates this educational activity for a maximum of 16.25 AMA PRA tion on research and techniques in their daily practice. Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Unlabeled or Unapproved Use of Drugs or Devices Disclosure Statement In accordance with the Essential Areas and Policies relating to commercial support, the audience is advised that one or more presentations in this As a sponsor accredited by the ACCME, the American Urological Association continuing medical education activity may contain reference(s) to unla- Education and Research, Inc. must insure balance, independence, objectivity beled or unapproved uses of drugs or devices. Please consult the prescrib- and scientific rigor in all its sponsored activities. All faculty participating in a ing information for full disclosure of approved uses. CME accredited sponsored program are expected to disclose to the audience any significant financial interest or other relationships with commercial sup- Disclaimer porters. The intent of this disclosure is not to prevent a speaker with a significant financial interest or other relationship from making a presentation, but The opinions and recommendations expressed by faculty/authors and rather to provide listeners with information on which they can make their other experts whose input is included in this program are their own and own judgments. The AUA manages and resolves the conflicts of interest with do not necessarily represent the viewpoint of the American Urological commercial support in advance of the program and uses a variety of mecha- Association Education and Research, Inc. nisms to ensure balance and fairness in the program presentations. It remains for the audience to determine if the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusion.

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING THURSDAY, SEPTEMBER 7, 2006 • SCHEDULE AT-A-GLANCE

Time/Room Confederation 1 Confederation 2,3

7:00 a.m.

8:00 a.m.

Live Surgery Telecast 1st Case from London, Ontario, John D. Denstedt, M.D. 9:00 a.m.

Intuitive Robotics Video Session 10:00 a.m.

Live Surgery Telecast 2nd Case from London, Ontario, John D. Denstedt, M.D. 11:00 a.m.

Exhibit Hall Sneak Peak Luncheon 12:00 p.m.

1:00 p.m. State-of-the-art Lectures 1 - 3:00 2:00 p.m.

Coffee Break 3:00 p.m.

State-of-the-art Lectures 4:00 p.m. 3:30 - 5:30

5:00 p.m.

Exhibit Hall Opening Welcome Reception (Platinum Supporters 6:00 p.m. Plaques presented)

7:00 p.m.

7:00 a.m. - 4:00 p.m. — Registration open in 4th ﬂoor foyer Events Telecasts 2:00 - 4:30 a.m. — Hospitality Room, New Brunswick Lectures Breaks 7:30 - 10:00 p.m. — Dine-Around Video Session Poster Session 1

Time/ Confederation 1 Confederation Province 1 Province 2 Les Saisons British Columbia Room 2,3 (Nursing Program) Industry Sponsored Breakfast Symposium — 7:00 Issues and Controversies 6:45-7:45 a.m. Residents in the Management of Breakfast a.m. Prostate Cancer with Leonard G. Gomella, M.D. Hormaonal Therapy Breakfast (Watson Pharma)

8:10 - 8:30 a.m. — Welcome 8:00 Podium Session 1 — Prostate Cancer a.m. (Papers 1 - 7)

View Posters Guest Lecture: Lymph Node 8:30 - 9:55 a.m. — Interstitial Dissection in GU Surgery, Cystitis: Past, Present, and Future, 9:00 Michael Koch, M.D.. Vicki Ratner, M.D. a.m. Point-Counter-Point: Open vs. Robotic vs Laparoscopic Prostatectomy Moderated Drs. Joseph, Carroll, Moinzadeh Poster Session I — Prostate View Posters Cancer Break (P1-17) 10:00 - 10:15 a.m. - Break 10:00 a.m. Moderated Poster 10:15 - 11:30 a.m. Podium Session II — Bladder Cancer Session II — Vesicoureteral Reﬂux: Is there a (Papers 8-14) Laparoscopy, Infertility & New Perspective? Stones (P18-28) Jyoti Upadhyay, M.D. 11:00 a.m. Guest Lecture — Superﬁcial Bladder Cancer, Leonard Gomella, M.D.

12:00 Visit Exhibit Hall/Lunch Exhibit Hall Open Lunch in Exhibit Hall p.m. (Lunch Served)

1:00 Podium Session III — Pediatric Urology p.m. (Papers 15-22) 1:30 - 2:45 p.m. — GU Pathology (Why are they having a Guest Lecture — Current Concepts in Pathologist talk?) the Management of Posterior Urethral Steve K. Landas, M.D. 2:00 Valves, Curtis Sheldon, M.D. View Posters p.m. Visit Exhibit Hall 2:45 - 3:15 p.m. — Visit Exhibits Moderated Stump the Professor Drs. Michael O. Poster Session III Koch, Leonard Gomella, Peter Carroll 3:00 — Pediatrics, Female p.m. Podium Session IV — Prostate Urology, Basic & 3:15 - 4:15 p.m. Ask Your Colleagues: Cancer Recurrence/Biopsies (Papers General Urology Management of Adult and Pediatric Enuresis, 23-26) (P29-45) Obstructive Uropathy, and Urinary tract Infections, Rina Brothers, R.N., N.P., Guest Lecture — Prostate Cancer, Susan Lipsy, R.N., MS, CUNP, Lisa Lynch, Peter Carroll, M.D. R.N., ONC, Maryellen Sheridan, R.N., 4:00 MS, and Frances Stewart, R.N., NCA p.m. 4:30 - 5:15 p.m. — Strategic Retirement and Estate Planning 5:00 Solutions, Joel M. Blau, CFP p.m. (Spouses invited) 7:00 a.m. - 4:00 p.m. — Registration open in 4th ﬂoor foyer Events Telecasts 8:30 a.m. - 4:00 p.m. — Hospitality Lounge, New Brunswick Lectures Breaks 6:00 - 10:00 p.m. — Fun Night, Canadian War Museum Podium Sessions Poster Session 2

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING SATURDAY, SEPTEMBER 9, 2006 • SCHEDULE AT-A-GLANCE Time/ Confederation Les Saisons Room Confederation 1 2,3 Province 1 Province 2 (Nursing Program) 6:30 - 8:00 7:00 a.m. Residents Annual Business Meeting Breakfast — a.m. Nikhil Shah, Breakfast M.D.

8:00 Bashar Podium Session V: Laparoscopy View Posters Female Sexual Dysfunction, a.m. (Papers 27-34) Omarbasha, M.D.

Slotkin Lecture — Computer Assisted Robotic Surgery (CARS): New Paradigms in Treatment of BPH, 9:00 A Paradigm Shift After 2600 Cases Mani Menon, M.D. Poster Session IV — Grannum R. Sant, M.D. Other Cancer a.m. Visit Exhibit Hall (P46-62) Break — Visit Exhibit Hall

Podium Session VI: Stones (Papers 35-38) Erectile Dysfunction — Current 10:00 Exhibit Hall Open Evaluation and Management, a.m. Guest Lecture — Surgical Management of Patients Johathan D. Block, M.D., Ph.D., M.B.A., with Complex Nephrolithiasis, Dean Assimos, M.D. PFPM Guest Lecture — Interstitial Cystitis — Update on Comparison of Current Treatment 11:00 Pathophysiology and Treatment, Grannum R. Sant, M.D. Strategies for Overactive Bladder, Urge Urinary Incontinence, and Female Stress a.m. US-Canadian Urinary Incontinence in Canada and the Socioeconomics United States, Kevin Victor Power, M.D. Update, James Regan, M.D., 12:00 Allan B. Patrick, M.D. p.m.

1:00 p.m.

2:00 p.m.

3:00 p.m.

4:00 p.m.

5:00 p.m.

6:00 p.m.

7:00 7:00 - 10:00 p.m. Presidents Reception and Banquet p.m.

6:15 - 9:00 a.m. — 5K Run, Rideau Canal (Registration 8:30 - 11:30 a.m. — Hospitality Lounge, New Brunswick @ 6:15 a.m.) 1:00 - 5:30 p.m. — Golf Tournament, Château Cartier 7:00 - 10:00 a.m. — Registration open on 4th ﬂoor 1:30 - 4:30 p.m. — Tennis, Ottawa Athletic Club foyer 3

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ NORTHEASTERN SECTION BOARD OF DIRECTORS 2005-2006 President Representatives Gabriel P. Haas, M.D. AUA Board of Directors Syracuse, NY Datta G. Wagle, M.D. President-Elect/Secretary Williamsville, NY Barry A. Kogan, M.D. Canada Albany, NY Allan B. Patrick, M.D. Past President Fredericton, New Brunswick John D. Denstedt, M.D. New York London, Ontario Robert D. Mayer, M.D. Secretary-Elect Rochester, NY Edward M. Messing, M.D. Pennsylvania Rochester, NY David A. Corral, M.D. Treasurer Pittsburgh, PA Anne-Marie Houle, M.D. At-Large Montreal, Quebec Michael E. Moran, M.D. Historian Albany, NY Zahi Makhuli, M.D. At-Large Syracuse, NY Ross G. MacMahon, M.D. Winnipeg, Manitoba

2005-2006 NS-AUA COMMITTEE LISTING Arrangements Committee George Slotkin Lecture Committee Nominating Committee Gabriel P. Haas, M.D., President Gabriel P. Haas, M.D., Chair John D. Denstedt, M.D.,Chair James W.L. Wilson, M.D. Barry A. Kogan, M.D. Mark F. Bellinger, M.D. John Eric Mahoney, M.D. John D. Denstedt, M.D. Edward M. Messing, M.D. Awards Committee Health Policy Committee Joel Byron Nelson, M.D. Program Committee John D. Denstedt, M.D., Chair J. Paul Whelan, M.D., Chair Gabriel P. Haas, M.D. Joseph M. Greco, M.D. Imad Salah Nsouli, M.D., Chair Ron Hrebinko, M.D. Allan Beatteay Patrick, M.D. Hassan Razvi, M.D. Bylaws Committee Ronald Paul Kaufman Jr., M.D. David Anthony Corral, M.D. Investment Committee Ronald P. Kaufman, M.D. Barry A. Kogan, M.D., Chair Jyoti J. Upadhyay, M.D. Gerald Benjamin Brock, M.D. Anne-Marie Houle, M.D., Chair D. Robert Siemens, M.D. Stephen Edward Pautler, M.D. Mark F. Bellinger, M.D. Scholarship Research Committee Development Committee Joseph L. Chin, M.D. John D. Denstedt, M.D. Joel Byron Nelson, M.D., Chair J. Paul Whelan, M.D., Co-Chair Judicial Committee Sender Herschorn, M.D. Datta G. Wagle, M.D., Co-Chair Erdal Erturk, M.D. Joseph M. Greco, M.D. Joseph L. Chin, M.D., Chair Badar Munir Mian, M.D. David B. Patrick, M.D. Mark F. Bellinger, M.D. Anne-Marie Houle, M.D. Kevin Pranikoff, M.D. Jean Volny Joseph, M.D.

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING The Northeastern Section of the American Urological Association would like to thank the following companies for their contribution and support of the 2006 Annual Meeting.

Platinum Level Supporters ($35,000 and above) Astellas Pharma US, Inc. Boehringer-Ingelheim Pharmaceuticals, Inc. Gyrus ACMI sanoﬁ-aventis U.S. Inc. Pﬁzer Inc

Gold Level Supporters ($25,000 - $34,999) Bayer Oncology Watson Pharmaceuticals, Inc.

Silver Level Supporters ($15,000 –24,999) Intuitive Surgical

Additional Support Coherent, Inc. Cook Canada Cook Urological GlaxoSmithKline Novartis sanoﬁ-aventis Canada

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ NORTHEASTERN SECTION OF THE AMERICAN UROLOGICAL ASSOCIATION DEVELOPMENT COMMITTEE Datta G. Wagle, M.D., Co-Chair David B. Patrick, M.D. Main Urology Associates 1700 Third Street 6645 Main Street Beaver, PA 15009 Williamsville, NY 14221 Phone: 724-775- Phone: 716-631-0932 Fax: 724-775-4409 Fax: 716-631-2826 E-mail: [email protected] Anne-Marie Houle, M.D. Hopital Sainte-Justine J. Paul Whelan, M.D., Co-Chair 3175 Cote-Sainte Catherine, A-4 McMaster Institute of Urology Montreal PQ H 3T 1C5 50 Charlton Ave East Canada Hamilton, ON L8N 4A6 Phone: 514-345-4931 (x 6811) Canada Fax: 514-345-4824 Phone: 905 521-6014 E-mail: [email protected] Fax: 905 528-3043 E-mail: [email protected] Jean Volny Joseph, M.D. Box 656 Joseph M. Greco, M.D. 601 Elmwood Ave Windsong Medical Park Rochester, NY 14642 55 Spindrift Drive. #240 Phone: 716 273-1688 Williamsville, NY 14221 Fax: 585 756-5457 Phone: 716-631-9600 E-mail: [email protected] Fax: 716-631-9251 E-mail: [email protected]

Administrative Offices Mr. Drew Shifflet Executive Administrator 1000 Corporate Boulevard Linthicum, MD 21090 Phone: 410-689-4025 Fax: 410-689-3837 E-mail: dshiffl[email protected] Web: www.auanet.org/northeastern

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING NORTHEASTERN SECTION RESEARCH & EDUCATION FUND

Research and Education This fund was initiated in 1995 by Searle Canada and Searle USA. The purpose of this fund is to assure the membership of the NS-AUA continuing excellence in research and educational activity within our Section. Scholarship Program —Young Investigators Awards The NS-AUA Scholarship Program was established in 1998 to provide financial scholarships to support research and educational projects. The program currently offers up to two scholarship awards annually, of $30,000. These Young Investigator Awards provide financial assistance to a researcher in basic or clinical sciences related to urology, and to acquiring, developing or improving his or her knowledge and skills in a specific aspect of the specialty. Urology Residents and Fellows Beginning in 2002, the Section began offering support to 15 Urology Residency Programs in its geographical region by providing two (2) $1,000 stipends, per urology program, to help offset costs associated with sending residents/fellows to the Annual Meeting. This funding is sent directly to the teaching Institution. Contributions to the Research and Education Fund have also enabled the Section to provide special programming and events specifically tailored for urology residents.

Through the generosity of our Section members and corporate supporters, the Research and Education Fund continues to grow. We gratefully acknowledge and thank: Abbott Labs, LTD. Janssen-Ortho Abbott - Canada Karl Storz Endoscopy – America, Inc. – Alza Pharmaceuticals USA and Canada Amgen and Praecis Liebel-Flarsheim Astra Zeneca Pharmaceuticals, Inc. Canada Lilly Icos Astra Zeneca Pharmaceuticals, Inc. USA Merck Aventis Merck & Co., Inc. – Urology Specialty Group Aventis Canada Merck Frosst Canada Aventis Oncology USA Novartis Oncology Bard Urological Novartis Pharmaceuticals Bayer Corporation NS-AUA Members Berlex, Canada Ortho McNeil Boehringer Ingelheim – Canada Pfizer Roerig Boehringer Ingelheim Pharmaceuticals, Inc. Pfizer USA Boston Scientific/Microvasive Pfizer Pharmaceuticals Group-Canada Bristol Meyer Squibb Pharmacia Corporation Cook Canada, Inc. Pracaecis Pharmaceuticals, Inc. Cook Urological Proctor & Gamble Pharmaceuticals Eli Lilly Corp. Sanofi-Synthelabo Canada Glaxo-Smith Kline Sanofi-Synthelabo, Inc. Gyrus ACMI Schering Oncology/Biotech Healthtronics, Inc. Tap Pharmaceuticals, Inc. Hoechst Marion Roussel Canada and USA Yamanouchi USA, Inc. Indevus Pharmaceuticals

Excerpt from the Waterways chapter: “No history of the Northeastern Section is complete without a short biography of this indefati- gable urologist. Dr. George E. Slotkin (1890-1971) (Fig. 10-13) was born in New York City but soon moved with his parents to Buffalo, NY, where he spent his professional career. We acknowledge him today as a founder, the first benefactor, and the first historian of the NS, but there is more to his story. If one were to hold up a mirror to the changing face of urology in the first half of the 20th century, it would be well reflected with an image of George E. Slotkin. A graduate of the University of Buffalo Medical School, Dr. Slotkin did postgraduate work at the New York City Post Graduate Hospital, the University of Vienna, and the University of Budapest. In 1918, he became a clinical professor of urology at the University of Buffalo. During the late 1940s, his clinical interest was tuberculosis of the urinary tract, which he treated with chalamagoric acid. Even though results of his work in this area remain inconclusive, other fruits of his career do not. Friends and colleagues of his time were fond of saying, ‘George Slotkin has three loves: urology, his wife Helene, and his Rolls Royce...not necessarily in that order!’ His early work, ‘Nephroptosis, a resurrected disease,’ was published in The Urologic and Cutaneous Review in 1938. His later work with E.A. Mercer, ‘Case of epispadias with a double urethra,’ was published in The Journal of Urology® in 1953. Obviously, this change in his work reflects the change in urology from its early focus on genitourinary disease to its present focus as a surgical specialty. Dr. Slotkin was named Clinical Professor of Urology Emeritus in 1954 by the University of Buffalo Medical School and continued his private practice until 1964. After retirement, he continued to write, contributing a fascinating chapter about the history of the Northeastern Section to History of Urology. It is a priceless, logical record of carefully researched facts. His obituary notice implies that he may have been the first American invited to join the Canadian Urological Association. Dr. and Mrs. Slotkin did not have any children; his estate included a generous bequest to the Northeastern Section to provide funding for invited guest speakers at our annual meetings.” Meyer, Robert, M.D. and Margaret, “History of the Northeastern Section of the American Urological Association: Waterways.”

The American Urological Association Centennial History 1902–2002. Ed. Lawrence Jones, M.D. and Paul Peters, M.D. Baltimore: American Urological Association, 2001. 585-642. GEORGE F. SLOTKIN LECTURERS 1975 Prof. Willie L. M. Gregoir, Brussels, Belgium 1992 Michael E. Mitchell, M.D., Seattle, Washington 1976 J. Engelbert Dunphy, M.D., San Francisco, California 1993 Donald S. Coffey, M.D., Baltimore, Maryland 1977 B. E. Christopher Nordin, M.D., Leeds, England 1994 Carl Olsson, M.D., Larchmont, New York 1978 Donald Smith, M.D., Piscataway, New Jersey 1995 Peter Scardino, M.D., Houston, Texas 1979 J. Genest, M.D., Montreal, Quebec 1996 Bernard M. Churchill, M.D., Los Angeles, California 1980 Joseph J. Kaufman, M.D., Los Angeles, California 1997 Peter R. Carroll, M.D., San Francisco, California 1981 Roger C. B. Pugh, M.D., London, England 1998 Joyce Lisa Tenover, M.D., Atlanta, Georgia 1982 Donald S. Coffey, M.D., Baltimore, Maryland 1999 Richard D. Williams, M.D., Iowa City, Iowa 1983 Martin I. Resnick, M.D., Cleveland, Ohio 2000 Gerry G. Blaivas, M.D., New York, New York 1984 Willet F Whitmore, Jr., M.D., New York, New York 2001 Alvaro Morales, M.D., Kingston, Ontario 1985 Peter Scardino, M.D., Houston, Texas 2002 Edson Pontes, M.D., Detroit, Michigan 1986 William Fair, M.D., New York, New York 2003 Gerald L. Andriole, M.D., St. Louis, Missouri 1987 John Duckett, M.D., Philadelphia, Pennsylvania 2004 Mustafa Elhilali, M.D., Montreal, Quebec 1988 Anthony R. Mundy, M.D., London, England 2005 Margaret Sue Pearle, M.D., Dallas, Texas 1989 Robert Jeffs, M.D., Baltimore, Maryland 2006 Mani Menon, M.D., Detroit, Michigan 1990 Charles J. Devine, M.D., Norfolk, Virginia 1991 Thomas Stamey, M.D., Stanford, California

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING 2006 INVITED GUEST SPEAKERS Dean G. Assimos, M.D. Business Breakup (published by AMA Press) and most recently Professor of Surgical Sciences The Prescription for Financial Health: An Authoritative Guide Department of Urology for Physicians (published by Greenbranch Publishing). Wake Forest Univeresity School of Medicine Winston-Salem, NC Gerald B. Brock, M.D. Professor, Department Of Surgery, Division Of Urology Dean Assimos is currently vice-chairman of the department of University Of Western Ontario urology and professor of surgical sciences at the Wake Forest London, Ontario University School of Medicine in Winston-Salem, North Carolina. Canada He received his B.S. from Purdue University in 1974 and his M.D. degree from Loyola Stritch School of Medicine in 1977. He Dr Gerald Brock is currently Professor in the department of completed his urology residency at Northwestern University in Surgery Division of Urology at the University of Western Ontario, 1983. He was a clinical fellow in intra-renal surgery and stone Canada. He runs a large tertiary care erectile dysfunction and disease at Wake Forest in 1983-1984 and subsequently was an infertility clinic seeing over 1500 new consults annually. AUA research fellow at the same institution from 1984-1986. In addition he runs a productive basic research animal lab His clinical interests are the medical and surgical management focusing on the effects of disease states on erectile physiology. of patients with nephrolithiasis, and ureteral stricture disease. His basic science research focuses on the effects of dietary He is the author of more than 100 peer reviewed journal arti- oxalate, endogenous oxalate synthesis and primary hyperox- cles, 20 book chapters and has been awarded more than 20 aluria. He remains an active member of the AUA stone guide- research prizes for his work. He sits on the editorial board of lines panel and currently serves on the AUA practice guidelines several journals including the J. Sexual Medicine, J. Andrology committee. He is a member of a number of organizations and the Canadian J. Urology. including the AUA, A.A.G.U.S., Endourology Society and the ROCK society. He serves on the editorial board of the Journal of Peter R. Carroll, M.D. Endourology, Urologic Research and Med Reviews in Urology. Professor and Chair Department of Urology Joel M. Blau, CFP Ken and Donna Derr-Chevron Distinguished Professor President University of California, San Francisco MEDIQUS Asset Advisors, Inc. Chicago, IL Dr. Peter Carroll received his undergraduate training at the University of California, Berkeley. After graduating with honors Joel M. Blau is President of MEDIQUS Asset Advisors, Inc. Prior from Georgetown University School of Medicine, he came to to forming the firm, he was Vice President and Senior Financial UCSF for his general surgery training and urology residency. He Counselor for AMA Investment Advisers, L.P., and an affiliate of completed a fellowship in Urologic Oncology at Memorial-Sloan the American Medical Association. Mr. Blau has been responsi- Kettering Cancer Center before returning to join the faculty in ble for the analysis and design of client's financial plans. His the Department of Urology at UCSF. areas of expertise include wealth preservation through estate tax planning, retirement, investment, and insurance planning. A Dr. Carroll organized the Urologic Oncology Service, one of the CERTIFIED FINANCIAL PLANNER™ certificant, Mr. Blau earned most active multidisciplinary programs at UCSF. In 1996, he his bachelor's degree in business from Drake University, with a assumed chairmanship of the UCSF Urology Department, con- major in finance and a specialization in investments. His month- sistently ranked as one of the top urology departments in the ly financial articles are included in many state, county and country by U.S. News and World Report. He holds the Ken and national medical specialty society publications. He is a frequent Donna Derr-Chevron Distinguished Professorship, and he has public speaker and has given financial seminars for the served as Surgeon-in-Chief of the UCSF Comprehensive Cancer American Medical Association as well as other professional Center since 2003. medical associations, hospitals, and clinics. Mr. Blau has been included in "Who's Who In Finance and Industry" and "Who's Dr. Carroll has authored or co-authored over 323 publications. Who of Emerging Leaders of America." He is a member of the He is Associate Editor of the Journal of Urology® and plays a Institute of Certified Financial Planner licensees and holds vari- substantive role in other journals. He is an active member of ous securities and insurance licenses. Mr. Blau has co-authored numerous professional medical societies. He is currently princi- Medical Practice Divorce: Successfully Managing a Medical pal or co-investigator of 7 peer-reviewed research grants, includ- 9

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ ing the UCSF Prostate Cancer SPORE, funded by the National and the prevention of prostate cancer. He has published his Institutes of Health. His major professional interests are the findings in such journals as Journal of Urology® and Urology, study and management of urologic cancers, innovative methods and has presented at a number of national meetings, including of urinary tract reconstruction, and the impact of cancer detec- American Urological Association annual meetings. tion and treatment on quality of life. Harris E. Foster Jr., M.D. Sam S. Chang, MD Professor of Surgery Associate Professor Section of Urology Department of Urologic Surgery Yale University School of Medicine Vanderbilt University School of Medicine New Haven, CT Nashville, Tennessee Dr. Harris E. Foster, Jr., M.D. received his undergraduate degree A graduate of Princeton University and Vanderbilt University, in Biology from the University of Michigan in Ann Arbor. He sub- Dr. Chang completed his residency in urologic surgery at sequently attended the University of Miami School of Medicine Vanderbilt and then completed a two year fellowship in uro- in Miami, Florida where he graduated with honors. Dr. Foster logic oncology at Memorial Sloan-Kettering Cancer Center in completed his preliminary general surgery and urology training New York, New York where he was Chief Fellow. His current at the University of Michigan Hospitals. He subsequently joined position is Associate Professor of Urologic Surgery at the faculty at the Yale University School of Medicine where he is Vanderbilt University. At Vanderbilt, he received a CaPCURE currently Professor of Surgery in the Section of Urology. Dr. Young Investigator Award as well as being named as an AUA- Foster has been involved in many of the pivotal clinical trials EAU Academic Exchange Fellow. investigating the effects of medical therapy on the treatment of lower urinary tract symptoms secondary to benign prostatic A member of numerous organizations, currently he is a mem- hyperplasia and their effects on progression of this disease. In ber of the AUA Foundation Prostate Advisory Board and the addition, he has been involved in attempts to explain some of Vice-Chairman of the AUA Superficial Bladder Cancer the results of these investigations utilizing molecular biological Guidelines Panel. He also serves on the Executive Committee techniques. In particular he has been studying the effects of of the SUO and is the Chair of the Genito-Urinary Task Force chronic administration of alpha adrenergic antagonists on the for the AJCC in charge of cancer staging. alpha receptor system in the rat model. Dr. Foster also has interests in interstitial cystitis and is currently the chair of the He has authored more than 100 publications with current National Institutes of Health sponsored Interstitial Cystitis research interests in diagnostic and treatment options for Clinical Research Network. prostate, bladder and renal cancer. Leonard G. Gomella, M.D. Gregg R. Eure, M.D. The Bernard Godwin Jr. Professsor of Prostate Cacner Chairman, Department of Urology Thomas Jefferson University Assistant Professor of Urology 1025 Walnut Street, Room 1102 Eastern Virginia Medical School Philadelphia, PA Virginia Beach, VA Dr. Leonard Gomella is the Bernard W. Godwin, Jr. Professor of Gregg R. Eure, MD, FACS, is Assistant Professor of Urology at Prostate Cancer and Chairman of the Department of Urology at Eastern Virginia Medical School in Norfolk, Virginia. Dr. Eure also Jefferson Medical College and Associate Director of the Kimmel maintains a private urology practice with Devine-Tidewater Cancer Center in Philadelphia. Dr. Gomella completed his med- Urology in Virginia Beach, a Division of Urology of Virginia. ical school, general surgery and urology training at the University Dr. Eure received his medical degree from the Medical College of Kentucky in Lexington, Kentucky. After a Urologic Oncology of Virginia in Richmond, where he also completed his general Fellowship in the Surgery Branch of the National Cancer Institute surgery training. He completed a residency in urology at the in Bethesda, Maryland and he joined the faculty of Jefferson Eastern Virginia Graduate School of Medicine. Dr. Eure is a fel- Medical College in 1988 and was appointed Chair in 2002. low of the American College of Surgeons. He was recently hon- ored with being chosen into the American Urological Dr. Gomella is involved in both basic science and clinical research Association’s Young Urologist Leadership Program. in the development of new diagnostic techniques and treatments As Director of Clinical Research for Devine Tidewater Urology for prostate, bladder and kidney cancer. Dr. Gomella's team was and Urology of Virginia, Dr. Eure is an active researcher in vari- first to use RT-PCR to detect micrometastasis metastasis in 10 ous areas of urologic disease, including the treatment of BPH patients with prostate cancer. He serves as Urology Chair for

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING RTOG and is also recognized as an expert in urologic Vattikuti Urology Institute. Dr. Menon is tenured professor of laparoscopy, having initiated Jefferson’s program in 1990. urology at Case Western Reserve University School of Medicine, Cleveland, OH. In addition to having given over 350 presentations, he has writ- ten over 250 papers, book chapters and monographs in the field Dr. Menon is one of the foremost Urologists in the United States. of Urology and has served on multiple editorial boards. Dr. He graduated from JIMPER Pondicherry and did his residency in Gomella has authored and edited over forty books for medical Urology at the Brady Urological Institute at John Hopkins, students, house officers, and practicing physicians, many of Baltimore, USA with Dr. Patrick Walsh. While working with Dr. which have been translated into foreign languages. He has been Walsh, Dr. Menon developed a technique to measure androgen recognized for many years in “Best Doctors in America”, receptors in the human prostate, the first such measurement. Later, Philadelphia Magazine’s “Top Doctors” for Urologic Oncology he moved to Washington University in St. Louis where, within two and received a "Volunteer Achievement Award" in 2000 from years, he became the youngest tenured clinical faculty member.The the Pennsylvania Chapter of the American Cancer Society and an techniques involved in nerve-sparing radical prostatectomy were “NCI Achievement Award”. In 2005, he became President of the being developed by Walsh when Dr. Menon was at Hopkins. This Mid-Atlantic Section of the American Urologic Association. enabled him to become one of the first surgeons in the world to perform this delicate operation, while he was in St. Louis. In 1983, Michael Koch, M.D. he moved to the University of Massachusetts Medical School, to Chairman and Professor start the Division of Urological and Transplantation Surgery there. Indiana University School of Medicine At age 34, he became the youngest chairman of Urology in the Indianapolis,IN USA. Under Dr. Menon’s leadership, the Department at the University of Massachusetts became the largest in New England Dr. Koch completed his general surgery training and a year of and one of the best in the country as ranked by the U.S. News and research fellowship at Dartmouth Medical School from 1981 World Report. In 1997, Dr. Menon was recruited to Henry Ford though 1984 and then went on to complete his urology training Hospital to invigorate the prostate cancer program there. and serve on the faculty at Vanderbilt University School of Medicine until 1998. Dr. Koch then was appointed as the Dr. Menon’s early interests were in reconstructive surgery for com- Chairman of the Department of Urology at Indiana University plex renal stones, while his research interests were in cell-crystal School of Medicine. He has an active interest in general oncolo- interactions as they relate to renal stones.At Henry Ford Hospital, gy with focused areas in prostate and bladder cancer. The Dr. Menon and his team developed techniques for robotic surgery Department at Indiana is internationally recognized for its con- in general and robotic prostatectomy in particular. The operation tributions to the treatment of most GU malignancies but partic- was redesigned to take advantage of the features of the robot. ularly testis cancer. Dr. Koch is a member of the GU Surgeons Arguably, the robotic approach that Menon has developed --- and is currently a trustee of the American Board of Urology. Vattikuti Institute Prostatectomy or VIP has become the gold standard for the surgical treatment of prostate cancer.The enhanced Katsuyuki Kuratsukuri nerve sparing techniques that the Menon team developed, the Assistant Professor “veil of Aphrodite”, promises to dramatically improve erectile func- Department of Urology tion outcomes following radical prostatectomy. Osaka City University School of Medicine Osaka, Japan Dr. Menon has published more than 250 papers, primarily in the field of robotic surgery, renal transplantation and urolithiasis. His Bio not available at time of publication. work has appeared in the major urological journals as well as in the Journal of Clinical Investigation, the Journal of Biological Mani Menon, M.D. Chemistry, the American Journal of Physiology, Proceedings of the National Academy and the New England Journal of Henry Ford Health System Medicine. He is a recipient of the Gold Cystoscope award of the The Raj and Padma Vattikuti American Urological Association and a member of the American Distinguished Chair Association of Genitourinary Surgeons and the Clinical Society of Director, Vattikuti Urology Institute GU Surgeons. He is a past member of the National Kidney and Detroit, MI Urological Disease Advisory Board and a Trustee of the American Board of Urology. Dr. Menon is profiled in the Best Doctors of Mani Menon, M.D., is chairman of the Department of Urology America and the International Who’s Who in Biology and at the Henry Ford Health System, the Rajendra and Padma Vattikuti Distinguished Chair in Oncology and Director of the 11

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ Medicine. He has been a visiting professor at various institutions James Regan, M.D. inside the USA and all across the globe, where he has lectured and James B. Regan, M.D. is currently Chair of the American Urological performed robotic surgery. Association’s Health Policy Council and the AUA representative to the AMA’s Relative Value Update Committee ( RUC ). He is a Tatsuya Nakatani member of the AUA Coding and Reimbursement Committee, Professor Patient Safety and Quality Improvement Committee and the Pay Department of Urology for Performance Task Force ( P4P ) and serves on the Health Policy Osaka City University School of Medicine Osaka Japan Committee of the Mid Atlantic Section of the AUA. He has previ- Osaka, Japan ously served as vice chair of the Health Policy Council and as the AUA’s representative to the AMA’s Practice Expense Advisory Bio not available at time of publication. Committee ( PEAC ). He is a former President of the Washington Urologic Society and is currently an Associate Professor of Urology Nobuyasu Nishisaka, M.D. at Georgetown University Medical Center in Washington, D.C. Assistant Professor Osaka City University School of Medicine Grannum R. Sant, M.D. Osaka, Japan VP and Head of Urology Portfolio US Medical Affairs, sanoﬁ-aventis Bio not available at time of publication. Professor of Urology, Tufts University School of Medicine

Allan B. Patrick, M.D. Born in Trinidad, Dr. Sant went to medical school in Dublin, Head of Urology, Ireland and did his urological residency at Tufts University. He River Valley Health stayed in Boston, became associate Urologist-in-Chief at the Fredericton, New Brunswick New England Medical Center Hospital, was program director at Canada Tufts in 1999, and became president of the New England section of the AUA in 2002. His research activity has focused on Dr. Allan Patrick was born in Chapleau Ontario but spent most of bladder function and dysfunction, ranging from the paraplegic his life in the Maritimes. Growing up in Fredericton, NB, he bladder to interstitial cystitis, which has led to a close associa- attended UNB where he received his BA in Biology and tion with the Interstitial Cystitis Association. Psychology in 1978. He then attended Dalhousie University where he graduated in Medicine in 1984. He took his Urology A senior member of the AUA, he is now Vice-President-Urology, training also at Dalhousie, finishing in 1989. A clinical fellowship U.S. Medical Affairs with sanofi-aventis. in Lithotripsy preceded his move to Fredericton where he has practiced since. He has held many positions at local regional and Peter C. Scardino, M.D. national levels. He has been Head of Urology for the Dr. Everett Chair, Department of Urology Chalmers Hospital and for the Region, River Valley Health, since Head, Prostate Cancer Program 1991. He was instrumental in the development of New Memorial Sloan-Kettering Cancer Center Brunswick's Mobile Lithotripsy Program, which has run success- New York, NY fully since 1993. He has served on the Board of Directors of the New Brunswick Medical Society and been member and Chair of Dr. Scardino is recognized internationally as an expert in the many NBMS Committees most recently as Chair of the NBMS early detection and surgical treatment of prostate cancer. He Information Technology Committee. He has served on the Board has pioneered techniques to decrease the effects of surgery on of the Canadian Urological Association, and been a member of urinary and sexual function and to increase the chances of long and Chair of the CUA Socioeconomics Committee. He is currently term control of cancer by total removal of the prostate. Dr. a Board representative of the Northeastern Section of the Scardino and his colleagues are using modern medical informat- American Urological Association. He has served on many indus- ics (artificial intelligence) to develop methods to predict the try advisory boards and has a busy speaking schedule. He runs a aggressiveness of prostate cancers and to determine whether general Urology practice, with emphasis on Female Incontinence some cancers may not need to be treated. His research has also and Clinical Trials. Dr. Patrick resides in Fredericton, NB with his focused on the identification of tissue and genetic markers that wife, Shelley, and children Rebecca, Ian and Katherine. signal the behavior of a prostate cancer. He has special experience in the treatment of prostate cancers that recur after surgery or radiation therapy and is currently studying the benefits of focal, image-guided therapy for very early cancers. 12

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Nakhil Shah, M.D. Robert G. Uzzo, M.D. Director, Minimally Invasive & Robotic Urology Associate Professor of Surgery Saint Joseph's Hospital of Atlanta Director of Urologic Oncology Research Urology Specialists of Atlanta, LLC Department of Urologic Oncology Atlanta, GA Fox Chase Cancer Center Temple University School of Medicine Dr. Nikhil L. Shah currently serves as the Director of Minimally Philadelphia, PA Invasive and Robotic Urology at Saint Joseph’s Hospital of Atlanta. He trained at the Vattikuti Urology Institute under Dr. Dr. Uzzo graduated summa cum laude and valedictorian from Mani Menon. During his training, Dr. Shah completed a NIH- Union College prior to attending Cornell University Medical College. NIDDK Urologist-Scientist Research Fellowship with Dr. Martin He completed 2 years of general surgical training at The New York Sanda at the University of Michigan. In addition, he earned a Hospital - Cornell Medical Center and Memorial Sloan Kettering degree in Health Management and Policy at the University of Cancer Center under the tutelage of G. Thomas Shires, M.D. Michigan’s School of Public Health. He has played an active role in leadership and policy related issues with the American Dr. Uzzo went on to complete 4 years of urologic surgical train- Medical Association (AMA) and the American Urologic ing also at The New York Hospital - Cornell Medical Center and Association (AUA). As a resident in Urology, Dr. Shah helped to Memorial Sloan Kettering Cancer Center under the guidance of create the AUA Residents Committee and served as its Chair for E. Darracott Vaughan M.D. He then went on to become an 3 years. He recently received a Distinguished Service Award from American Foundation for Urological Diseases Scholar in AUA President, Dr. Lawrence S. Ross, M.D., for his service, dedi- Urological Oncology at the Cleveland Clinic. In addition, he cation and leadership. Dr, Shah continues to remain active and completed a second fellowship in Renal Vascular Surgery and currently serves on the AUA’s Coding and Reimbursement Transplantation under the direction of Andrew C. Novick, M.D. Committee. In addition, he maintains an active role in local, national and international medical relief organizations for Dr. Uzzo is currently an Associate Professor of Surgery at Fox underserved people. Chase Cancer Center and Temple University School of Medicine. He has an active and funded lab researching the basic mecha- Taizo Shiraishi, M.D. nisms of kidney and prostate cancer. His clinical interests are in Professor minimally invasive urological oncology. He is the national urolo- Department of Pathology gy principle investigator for E.C.O.G. 2805 (A.S.S.U.R.E.) – a Mie University School of Medicine cooperative group trial studying the role of adjuvant tyrosine Tsu, Japan kinase inhibitors in intermediate and high-risk kidney cancer. He has authored more than 100 peer reviewed articles and chap- Bio not available at time of publication. ters in urology and urologic oncology and has been the recipient of numerous awards from the American Association of Cancer Research, the Society for Basic Urological Research and the Society of Urological Oncology.

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ PUBLICATION OF ABSTRACTS – 2006 The Board of Directors of the NS-AUA is pleased to announce that all accepted abstracts (podium and poster presentations) of the 2006 Annual Meeting have been published in the August issue of The Canadian Journal of Urology with generous support form GYRUS ACMI. A copy of this issue of the journal will be distributed when you arrive at the registration desk. On behalf of the authors, the Executive Officers extend its sincerest thanks and appreciation to The Canadian Journal of Urology and GYRUS ACMI for their generosity. The Canadian Journal of Urology is the officially endorsed journal of the Canadian Urological Association and is indexed in Medline and Index Medicus. The journal welcomes your articles or manuscripts for review and consid- eration for profitable publication. For additional information on submitting manuscripts or subscription information, contact: Editor- in-Chief, Lawrence H. Koltz, M.D., F.R.C.S.C.

The Canadian Journal of Urology (CJU) c/o Lena Georgieff 2330 Ward Street, Suite 604 St. Laurent, Quebec H4M 2V6 Canada Phone: 514-744-1184 Fax: 514-744-1138 E-mail: [email protected] Web: www.canjurol.com *A copy of the August edition of CJU is included in your bag for referencing this year’s abstracts.

Registration Hours Spouse Lounge Hours 4th Floor Foyer New Brunswick Room Wednesday: 5:00 – 7:00 p.m.. Thursday: 2:00 – 5:00 p.m. Thursday: 7:00 a.m. – 4:00 p.m. Friday: 8:00 a.m. – 4:00 p.m. Friday: 7:00 a.m. – 4:00 p.m. Saturday: 8:00 a.m. – 1:00 p.m. Saturday: 7:00 a.m. – 10:00 a.m.

Speaker Ready Room Exhibit Hall Hours Nova Scotia Room Confederation 2, 3 Thursday: 12:30 – 7:00 p.m. Thursday: 11:30 a.m. – 1:00 p.m. Friday: 6:30 a.m. – 7:00 p.m. 5:30 – 7:00 p.m. Saturday: 6:30 – 11:00 a.m. Friday: 10:00 a.m. – 3:00 p.m. Saturday: 9:00 a.m. – 12:00 p.m.

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING THURSDAY, SEPTEMBER 7, 2006 1:00 p.m. State-of-the-Art Lecture I Management of Prostate Cancer – Peter T. Scardino, M.D 8:30 – 9:30 a.m. Live Surgery 1st Case 1:30 p.m. State-of-the-Art Lecture II Percutaneous Nephrolithotripsy – Recent advances in the Pharmacologic John D. Denstedt, M.D. Treatment of BPH Harris E. Foster Jr., M.D., Moderator: Hassan Razvi, M.D. Supported by a grant from sanofi-aventis Urology At the conclusion of this session, participants will be able to: • Explain alternative surgical approaches and treatments for manage- 2:00 p.m. State-of-the-Art Lecture III ment of patients with kidney stones. The Role of PDE-5 Inhibitors in Erectile Dysfunction Gerald B. Brock, M.D. 9:30 – 10:30 a.m. Intuitive Robotic Video Session Supported by a grant from Pfizer Inc. Randy Fagin, M.D. At the conclusion of this session, participants will be able to: 2:30 p.m. State-of-the-Art Lecture IV • Describe the latest advances and techniques in robotics surgery for Chemotherapy Treatment for Hormone urology patients. Resistant Prostate Cancer: A Surgeon’s Perspective Sam S. Chang, M.D. 10:30 – 11:30 a.m. Live Surgery 2nd Case Ureteroscopy with Laser – Supported by a grant from sanofi Oncology John D. Denstedt, M.D. 3:00 – 3:30 p.m. Break Moderator: Hassan Razvi, M.D. At the conclusion of this session, participants will be able to: 3:30 – 5:00 p.m. State-of-the-art Lectures 5-7 • Explain alternative surgical approaches and treatments for manage- 3:30 p.m. State-of-the-Art Lecture VI ment of patients with kidney stones. New Treatment Paradigms for Renal Cell 11:30 a.m.–1:00 p.m. Sneak Peek Luncheon in Exhibit Hall Carcinoma Robert Uzzo, M.D. Supported by a grant from Bayer Pharmaceuticals 1:00 – 3:00 p.m. State-of-the-art Lectures 1-4 Moderators: Kevin Pranikoff, M.D. 4:00 p.m. State-of-the-Art Lecture VII James Wilson, M.D. An Update on Minimally Invasive At the conclusion of this session, participants will be able to: Treatments and the Evolution of Lasers – • Explain alternative pharmacologic treatments and management of Gregg R. Eure, M.D. patients with Prostate Cancer, Lower Urinary Tract Symptoms, Benign Supported by a grant from Boehringer–Ingelheim Prostatic Hyperplasia, and Renal Cell Cancer. 15

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ 4:30 pm State-of-the-Art Lecture VII Alberto Briganti, Paul Perotte, Francesco ABO-Incompatible Kidney Transplantation in Montorsi, Markus Graefen, Patrizio Rigatti, Japan Tatsuya Nakatani, M.D. Hartwig Huland, Pierre I. Karakiewicz “Management of BPH” Nobuyasu Nishisaka, University of Montreal Health Center, Montreal, M.D. PQ, Canada. 5:00 pm Current Status of Management of Prostate 8:24 a.m. 3. Treatment of Localized Prostate Cancer Cancer in Japan Katsuyuki Kuratsukuri, M.D. with High Intensity Focused Ultrasound “Latent prostatic cancer in the USA and Japan: (HIFU): Preliminary results of the North An international comparison and chronological American Experience change” Taizo Shiraishi, M.D. Magdy M. Hassouna, M.D. Ph.D. FRCSC Four presentations by Japanese guests supported by a FACS, William Orovan, M.D. FRCSC, grant from Astellas Pharma, Inc Edward Woods, M.D. FRCSC, Mohamed Elkelini, M.D., John Warner, M.D. FRCSC. 5:30–7:00 p.m. Exhibit Hall Grand Opening Don Mills Surgical Center, Toronto, ON, Canada. Welcome Reception 8:31 a.m. 4. Extended Lymphadenectomy Should be 7:00 p.m. Optional Dine Arounds Performed in Patients with PSA? 6, Biopsy Gleason Score 7-10 and Stage t2 or Higher Prostate Cancer Khaled Shahrour, M.D., Alberto Briganti, FRIDAY, SEPTEMBER 8, 2006 Felix K.-H. Chun, Francesco Montorsi, Patrizio Rigatti, Pierre I. Karakiewicz 6:45 – 7:45 a.m. Residents’ Breakfast Session University of Montreal Health Center, Montreal, 7:00 – 8:00 a.m. Industry Sponsored Breakfast Symposium PQ, Canada. Issues and Controversies in the Mangement 8:38 a.m. 5. Bicalutamide Monotherapy for of Prostate Cancer with Hormonal Therapy Biochemical Recurrence of Prostate Cancer Supported by a Grant from Watson Pharmaceuticals Seth A. Capello, M.D., Ronald P. Kaufman, 8:00 a.m. Welcome and Introduction Jr., M.D. Gabriel P. Haas, M.D. Albany Medical College, Albany, NY, USA. Northeastern Section of the AUA, President 8:45 a.m. 6. Prostate Biopsy by CT-Guided Paul F. Schellhammer, M.D. Percutaneous Paracoccygeal Technique American Urological Association, President-Elect David B. Lillie, M.D. 8:10 – 9:00 a.m. Podium Session I—Prostate Cancer SUNY at Buffalo, Kenmore, NY, USA. Moderators: Joel B. Nelson, M.D. 8:52 a.m. 7. What is the Ideal Extent of Pelvic Pierre I. Karakiwicz, M.D. Lymphadenectomy (PLND)? A Sensitivity Supported by a Grant from GlaxoSmithKline Analysis At the conclusion of this session, participants will be able to: Khaled Shahrour, M.D., Alberto Briganti, • Describe areas of clinical research in prostate cancer, and identify areas Felix K.-H. Chun, Francesco Montorsi, of controversy in the treatment of prostate cancer patients. Patrizio Rigatti, Pierre I. Karakiewicz • Identify recent developments in the clinical and pathological staging of University of Montreal Health Center, Montreal, prostate cancer. PQ, Canada. • Describe pharmacological and surgical options for treating patients with different stages of prostate cancer. 9:00 a.m. Adjourn 8:10 a.m. 1. Extended Biopsies on Autopsy Prostates: 9:00 – 11:45 a.m. Tour Options for Spouses Staging of Microfocal Cancers Nicolas B. Delongchamps, M.D., Vishal 9:00 – 9:30 a.m. Guest Lecture: Lymph Node Dissection in Chandan, M.D., Richard Jones, Ph.D., GU Surgery Gregory Threatte, M.D., Mary Jumbelic, Michael Koch, M.D. M.D., Gustavo de la Roza, M.D., Gabriel P. Supported by a Grant from Haas, M.D. GlaxoSmithKline Upstate Medical University, Syracuse, NY, USA.

8:17 a.m. 2. The Predictive Accuracy of the Partin Tables in Men with PSA Values in Excess of 20 Ng/Ml May be Limited Vincent Fradet, M.D., Felix K.-H. Chun, 16

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING 9:30 – 10:00 a.m. Point Counterpoint 9:44 a.m. P4. Validation of a Nomogram Predicting the Open vs. Robotic vs. Laparoscopic Probability of Lymph Node Invasion (LNI) Prostatectomy Based on the Extent of Pelvic Moderator: TBD Lymphadenectomy (PLND) Panelists: Peter R. Carroll, M.D. Quoc-Dien Trinh, M.D., Alberto Briganti, Jean V. Joseph, M.D. Felix K.-H. Chun, Francesco Montorsi, Pierre Ali Moinzadeh, M.D. I. Karakiewicz Supported by a Grant from GlaxoSmithKline University of Montreal Health Center, Montreal, PQ, Canada. 9:30 – 10:30 a.m. Moderated Poster Session I— Prostate Cancer 9:47 a.m. P5. Effect of Surgical Margins on Cancer Moderators: Ali Moinzadeh, M.D. Control Outcomes After Radical J. Paul Whelan, M.D. Prostatectomy. When Do Margins Matter? At the conclusion of this session, participants will be able to: Elie Antebi, M.D., Christopher Porter, • Describe areas of clinical research in prostate cancer. Alberto Briganti, Felix K.-H. Chun, Paul • Identiﬁes factors that can predict lymph node invasion or positive margins Perrotte, Pierre I. Karakiewicz. University of • Identify areas of controversy in the treatment of prostate cancer patients. Montreal Health Center, Montreal, PQ, Canada. • Describe pharmacological and surgical options for treating patients with P6. different stages of prostate cancer. 9:50 a.m. Effect of Autologous Blood Transfusion on Predictive Accuracy of Biochemical 9:30 a.m. Welcome and Introductions Recurrence after Radical Prostatectomy Daniel J. Lewinshtein, M.D., Felix K.-H. 9:35 a.m. P1. Validation of a Nomogram for Prediction Chun, Alberto Briganti, Markus Graefen, of Side-speciﬁc Extracapsular Extension at Hartwig Huland, Francesco Montorsi, Radical Prostatectomy Patrizio Rigatti, Pierre I. Karakiewicz. Elie Antebi, M.D., Thomas Steuber, Markus University of Montreal Health Center, Montreal, Graefen, Felix K.-H. Chun, Hartwig Huland, PQ, Canada. Pierre I. Karakiewicz University of Montreal Health Center, Montreal, 9:53 a.m. P7. Surgical Margin Status in European PQ, Canada. Versus North American Patients at Radical Prostatectomy 9:38 a.m. P2. Number of Lymph Nodes Removed and Daniel J. Lewinshtein, M.D., Felix K.-H. Examined and the Continent of Origin Chun, Alberto Briganti, Luc Valiquette, Represent the Foremost Predictors of Markus Graefen, Francesco Montorsi, Lymph Node Invasion in Men with Patrizio Rigatti, Hartwig Huland, Pierre I. Clinically Localized Prostate Cancer Karakiewicz. Naeem Bojani, M.D., Felix K.-H. Chun, University of Montreal Health Center, Montreal, Alberto Briganti, Markus Graefen, Hartwig PQ, Canada. Huland, Andrea Gallina, Francesco Montorsi, Pierre I. Karakiewicz. 9:56 a.m. P8. PSA Represents a Highly Accurate University of Montreal Health Center, Montreal, Predictor of Pathologic Stage and Surgical PQ, Canada. Outcomes Elie Antebi, M.D., Felix K.-H. Chun, Alberto 9:41 a.m. P3. Clinical Complications of Extended Briganti, Sharokh F. Shariat, Francesco Lymphadenectomy (PLND) in Patients Montorsi, Markus Graefen, Patrizio Rigatti, Affected by Localized Prostate Cancer Hartwig Huland, Pierre I. Karakiewicz. Undergoing Radical Retropubic University of Montreal Health Center, Montreal, Prostatectomy at a Single Institution PQ, Canada. Daniel J. Lewinstein, M.D. Alberto Briganti, Felix K.-H. Chun, Francesco Montorsi, Mike 9:59 a.m. P9. A Comparison of Post-implant Dosimetry McCormack, Patrizio Rigatti, Pierre I. After Prostate Brachytherapy in Men with Karakiewicz Prostate Volumes Greater than and Less University of Montreal Health Center, Montreal, than 50 cc. PQ, Canada. Erin P. Gibbons, M.D., Ryan P. Smith, M.D., Sushil B. Beriwal, M.D., Krishna Komanduri, Ph.D, Ronald M. Benoit, M.D. University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ 10:02 a.m. P10. Signiﬁcant Upgrading Affects One in 10:20 a.m. P16. Natural Progression of Men Treated Four Men Diagnosed with Prostate Cancer with Hormonal Therapy After Radical Predictive Nomogram Prostatectomy and PSA Recurrence Naeem Bhojani, M.D., Felix K.-H. Chun, Quoc-Dien Trinh, M.D., Kyoung-Hwan Alberto Briganti, Luc Valiquette, Francesco Felix Chun, Alberto Briganti, Koichi Montorsi, Markus Graefen, Patrizio Rigatti, Kodama, Robert Gibbons, Roy Jnr. Correa, Hartwig Huland, Pierre I. Karakiewicz. Paul Perrotte, Pierre I. Karakiewicz. University of Montreal Health Center, Montreal, University of Montreal Health Center, Montreal, PQ, Canada. PQ, Canada.

10:05 a.m. P11. Improved Survival with Sipuleucel-T 10:23 a.m. P17. Impact of Ratio Between Gland Size (APC8015) in Men with Advanced Prostate and Number of Biopsy Cores on Repeat Cancer Prostate Biopsy: Development and Internal Laurence Klotz, M.D.1, Mark Frohlich, Validation of A New Repeat Biopsy M.D.2 Nomogram in Men Assessed with 10 or 1Sunnybrook & Women’s College HSC, Toronto, More Cores ON, Canada, 2Dendreon Corporation, Seattle, Vincent Cloutier, M.D., Felix K.-H. Chun, WA, USA. Alberto Briganti, Markus Graefen, Luc Valiquette, Hartwig Huland, Pierre I. 10:08 a.m. P12. The Effect of Surgical Volume on Karakiewicz. Failure Free Survival After Radical University of Montreal Health Center, Montreal, Prostatectomy in the Province of Quebec PQ, Canada. Claudio Jeldres, M.D., Serge Benayoun, Alvaro Ramirez, Paul Perrotte, Michael 10:00 – 10:30 a.m. Break McCormack, Francois Benard, Luc Moderated Poster Session II— Valiquette, Fred Saad, Pierre I. 10:30 – 11:30 a.m. Laparoscopy, Infertility and Stones Karakiewicz. University of Montreal Health Center, Montreal, Moderators: Jean V. Joseph, M.D. PQ, Canada. Anil Kapoor, M.D. At the conclusion of this session, participants will be able to: 10:11 a.m. P13. Poor Overall Survival in Men Treated • Describe innovative surgical procedures and their effect on the man- with Deﬁnitive Radiotherapy Without agement of patients with urinary tract disorders, including kidney can- Evidence of Disease Relapse—Are We cer, prostate cancer, ureteral injury and stones.. Treating too Many Men with Radiotherapy? • Discuss effect on smoking on sperm quality. Claudio Jeldres, M.D., Paul Perrotte, Michael McCormack, Fred Saad, Pierre I. 10:30 a.m. Welcome and Introductions Karakiewicz. 10:35 a.m. P18. Robot-assisted Extraperitoneal Radical University of Montreal Health Center, Montreal, Prostatectomy in Patients with Prior Hernia PQ, Canada. Surgery 10:14 a.m. P14. External Beam Radiotherapy Outcomes Judd Boczko, M.D., Seth Capello, M.D., in Septa- and Octogenarians. Dragan Golijanin, M.D., Ralph Madeb, Claudio Jeldres, M.D., Paul Perrotte, Jean- M.D., Erdal Erturk, M.D., Hiten Patel, Paul Bahary, Fred Saad, Pierre I. M.D., Jean V. Joseph, M.D. Karakiewicz. Strong Memorial Hospital, University of University of Montreal Health Center, Montreal, Rochester, Rochester, NY, USA. PQ, Canada. 10:38 a.m. P19. A Prospective Comparison Between 10:17 a.m. P15. A Critical Appraisal of the Ability of Extraperitoneal and Transperitoneal Robot- Body Mass Index (BMI) to Predict High assisted Radical Prostatectomy Grade Prostate Cancer (Pca) Judd Boczko, M.D., Seth Capello, M.D., Vincent Fradet, M.D., Felix K.-H. Chun, Mary Mathe, PA, Erdal Erturk, M.D., Hiten Alberto Briganti, Francois Bénard, Paul Patel, M.D., Jean V. Joseph, M.D. Perotte, Markus Graefen, Francesco Strong Memorial Hospital, University of Montorsi, Patrizio Rigatti, Hartwig Huland, Rochester, Rochester, NY, USA. Pierre I. Karakiewicz. 10:41 a.m. P20. Semen Parameters and DNA University of Montreal Health Center, Montreal, Fragmentation in a Smoking Mouse Model PQ, Canada. Eric A. Singer, M.D., MA, Sue Schoen, Changyong Feng, Ph.D., Gyun Jee Song, Ph.D., Matthew A. DiMaggio, BS, Jeanne 18

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING H. O’Brien, M.D. 10:59 a.m. P26. Stone-to-skin Distance Greater than University of Rochester Medical Center, F2-to-skin Distance has no Effect on Shock- Rochester, NY, USA. wave Lithotripsy Success Marc C. Smaldone, M.D.1, Bruce L. Jacobs, 10:44 a.m. P21. The Diagnosis of Late Onset M.D.1, Arlene M. Smaldone, DNSc, CPNP, Hypogonadism (Loh) Remains a Clinical CDE2, Daniel J. Ricchiuti, M.D.1, Timothy and Biochemical Dilemma D. Averch, M.D.1. Laurel E. Emerson, R.N., Research 1University of Pittsburgh Medical Center, Coordinator 1, Angela M. Black, R.N Pittsburgh, PA, USA, 2Columbia University Research Coordinator1, Michael Spevack 2, School of Nursing, New York, NY, USA Michael Spevack2, Irwin Kuzmarov 3, Richard Casey, M.D. FRCSC4, Serge Carrier, 11:05 a.m. P27. Predictors of Shock-wave Lithotripsy M.D. FRCSC5, Roland Tremblay, M.D.6 Success for Proximal Ureteral Calculi on 1Queens University, Kingston, ON, Canada, 2Ulta Non-contrast CT Med Inc, Pointe Claire, PQ, Canada, 3Ultra Med, Eric A. Singer, M.D., MA, Jared D. Pointe Claire, PQ, Canada, 4The Male Health Christensen, M.D., Judd Boczko, M.D., Centre, Oakville, ON, Canada, 5McGill Urology Susan Messing, MS, Jean V. Joseph, M.D., Associates, Montreal, PQ, Canada, 6CHUG. Erdal Erturk, M.D. CHUL, Ste. Foy, PQ, Canada. University of Rochester Medical Center, Rochester, NY, USA. 10:47 a.m. P22. Short-term Dutasteride Use Decreases Serum PSA But Has Minimal Effect on 11:08 a.m. P28. Effect of Gatorade on Urinary Stone Prostate Volume in Men with Prostate Risk Factors Cancer Prior to Robotic Prostatectomy Danielle D. Sweeney, M.D., Daniel J. William Badger, M.D.1, Michael Perrotti, Ricchiuti, M.D., Timothy D. Averch, M.D. M.D.2, Michael Moran3, James Belarmino, University of Pittsburgh, Pittsburgh, PA, USA. M.D.1, Daryl McLeod1 Podium Session II—Bladder Cancer 1Albany Medical Center, Albany, NY, USA, 2Saint 10:30 – 11:30 a.m. Peter’s Hospital, Albany, NY, USA, 3Saint Peter’s Moderators: Edward M. Messing, M.D. Hospital, Albany, NY, USA. J. Paul Whelan, M.D. At the conclusion of this session, participants will be able to: 10:50 a.m. P23. The Inﬂuence of Laparoscopy on • Describe areas of clinical research in bladder cancer. Partial Nephrectomy Rate for Small Renal • Identify factors that can affect outcomes in patients with bladder cancer. Masses • Describe current innovative pharmacological and surgical treatments for 1 William Badger, M.D. , Michael Perrotti, patients with bladder cancer. M.D.3, Michael Moran, M.D.2, Daryl McLeod1. 10:30 a.m. Welcome and Introductions 1 2 Albany Medical Center, Albany, NY, USA, Saint 10:35 a.m. 8. Competing Risks Nomogram Predicting Peter’s Hospital, Albany, NY, USA. the Probability of Bladder Cancer 10:53 a.m. P24. Impact of Robotics and Laparoscopy Recurrence After Cystectomy Can Reliably on Surgical Skills: A Comparative Study Distinguish Between Those Destined to Sasha Pavlov-Shapiro, M.D.1, Boris Recur and Those Who May Die of Other Kuvshinoff2, William E. Brady, MS2, Aftab Causes Before Recurrence Nida, BS1, Hyung Kim, M.D.2, James Vincent Fradet, M.D., Felix K.-H. Chun, Mohler, M.D.2, Khurshid A. Guru, MBBS2. Alberto Briganti, Shahrokh F. Shariat, 1University at Buffalo, Buffalo, NY, USA, Ganesh Palapattu, Arthur Sagalowsky, 2Roswell Park Cancer Institute, Buffalo, NY, USA. Seth Lerner, Mark Schoenberg, Pierre I. Karakiewicz. 10:56 a.m. P25. Open Repair for Benign Ureteral University of Montreal Health Center, Montreal, Strictures in the Modern Era of Endoscopic PQ, Canada. Management Anthony T. Corcoran, M.D., Mark C. 10:42 a.m. 9. Internal Validation of a Competing-Risks Smaldone, M.D., Daniel J. Ricchiuti, M.D., Survival Nomogram for Patients Treated Timothy D. Averch, M.D. with Cystectomy for Bladder Cancer University of Pittsburgh, Pittsburgh, PA, USA. Quoc-Dien Trinh, M.D., Alberto Briganti, Felix K.-H. Chun, Shahrokh F. Shariat, Arthur Sagalowsky, Seth Lerner, Mark Schoenberg, Pierre I. Karakiewicz. University of Montreal Health Center, Montreal, PQ, Canada. 19

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ 10:49 a.m. 10. Impact of Concomitant Carcinoma in 1:00 – 2:00 p.m. Podium Session III – Pediatrics Situ on Clinical Outcomes After Radical Moderators: Jyoti Upadhyay, M.D. Cystectomy Ann-Marie Houle, M.D. Vincent Pradet, M.D., Shahrokh F. Shariat, At the conclusion of this session, participants will be able to: Ganesh S. Palapattu, Pierre I. Karakiewicz, • Describe current areas of research in pediatric urology, and identify areas Mark P. Schoenberg, Seth P. Lerner, Arthur of controversy in treating pediatric patients with anticholinergic therapy. I. Sagalowsky, Yair Lotan. • Describe novel techniques in the management of children with hypospa- University of Montreal Health Center, Montreal, dias, ectopic ureteroceles and ueteropelvic junction obstruction. PQ, Canada. • Identify state-of- the-art diagnostic tools in the diagnosis and management of patients with enuresis, renal trauma and nonpalpable testicles. 10:56 a.m. 11. Delay in Radical Cystectomy Over 12 Weeks is Not Associated with Adverse 1:00 p.m. Welcome and Introductions Outcome: Results from the Bladder Cancer Research Consortium 1:04 p.m. 15. Refractory Nocturnal Enuresis: True Thierry Lebeau, M.D., Matthew E. Nielsen, Beneﬁts of Urology Referral Shahrokh F. Shariat, Pierre I. Karakiewicz, Suzanne Moyer, RN, William C. Hulbert, Seth P. Lerner, Arthur I. Sagalowsky, Mark M.D., Cheryl Kline, CPNP, Ronald P. Schoenberg, Ganesh S. Palapattu. Rabinowitz, M.D., Robert A. Mevorach, University of Montreal Health Center, Montreal, M.D. PQ, Canada. University of Rochester, Rochester, NY, USA.

11:03 a.m. 12.Prognostic Significance of Deep 1:11 p.m. 16.Radical Bulbar Dissection and TIP Muscular Invasion and Extravesical Urethroplasty to Correct Proximal Extension in Pathological Staging of Hypospadias with Severe Chordee: Bladder Cancer After Radical Cystectomy Applicability and Outcomes Quoc-Dien Trinh, M.D., Shahrokh F. Marc C. Smaldone, M.D., Glenn M. Shariat, Pierre I. Karakiewicz, Arthur I. Cannon, Jr., M.D., Ethan Polsky, M.D., Sagalowsky, Seth P. Lerner, Mark P. Steven G. Docimo, M.D. Schoenberg, Ganesh S. Palapattu. University of Pittsburgh Medical Center, University of Montreal Health Center, Montreal, Pittsburgh, PA, USA. PQ, Canada. 1:18 p.m. 17. Ectopic Ureteroceles in Duplex Systems: 11:10 a.m. 13. Predictive Accuracy, Sensitivity and Long Term Follow Up After a Staged Specificity of Nuclear Matrix Protein 22 and Approach Urine Cytology for Prediction of Recurrence Ming-Hsien Wang, M.D., Saul P. of Non-transitional Cell Carcinoma of the Greenfield, M.D., Pierre Williot, M.D., John Bladder M. Rutkowski. Daniel J. Lewinshtein, M.D., Serge Children’s Hospital of Buffalo, Buffalo, NY, USA. Benayoun, Alberto Briganti, Felix K.-H. 1:25 p.m. 18. Can CT Scan Findings Shorten the Chun, Shahrokh F. Shariat, Paul Perrotte, Recovery for Grade IV Blunt Renal Trauma Pierre I. Karakiewicz. in Children? University of Montreal Health Center, Montreal, Glenn M. Cannon, Jr., M.D., Marc C. PQ, Canada. Smaldone, M.D., Ethan G. Polsky, M.D., 11:17 a.m. 14. Robot-assisted radical Cystectomy Francis X. Schneck, M.D., Mark F. Bellinger, and Pelvic Lymph Node dissection; Initial M.D., Steven G. Docimo, M.D., Hsi-Yang Experience at Roswell Park Cancer Institute Wu, M.D. Khurshid A. Guru, M.D,1, Hyung L. Kim, Children’s Hospital of Pittsburgh, Pittsburgh, M.D.1, Pamela Piacente, PA1, Teresa PA, USA. 2 1 Danforth , Greg Zimmerman, M.D. , James 1:32 p.m. 19. Method to Diagnose Testicular Torsion L. Mohler, M.D.1. Using Near Infrared Fluorescence (NIRF) of 1Roswell Park Cancer Institute, Buffalo, NY, USA, Intravenous Indocyanine Green (ICG) 2 university of Buffalo, Buffalo, NY, USA. Dragan Golijanin, M.D., Ralph Madeb, 11:24 a.m. Discussion M.D., Ronald Wood, Ph.D., Jay E. Reeder, Ph.D., Robert Mevorach, M.D., William 11:30 a.m. Adjourn Hulbert, M.D., Ronald Rabinowitz, M.D., Edward M. Messing, M.D., Jean Joseph. 11:30 a.m.–12:00 p.m. Guest Lecture: Superficial Bladder Cancer Departments of Urology and Pathology URMC, Leonard G. Gomella, M.D. SMH, Rochester, NY, USA. 12:00 – 1:00 p.m. Exhibit Hall Open, Lunch Served 20

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING 1:39 p.m. 20. Early Experience with Laparoscopic Mohamed Elkelini, M.D., Magdy Pyeloplasty for Ureteropelvic Junction Hassouna, M.D., Ph.D., FRCSC, FACS. Obstruction in Children: Evolution of University of Toronto, Toronto, ON, Canada. Technique P31. Danielle D. Sweeney, M.D., Christine Kim, 3:11 p.m. Peripheral Benzodiazepine Receptor M.D., Francis X. Schneck, M.D., Steven G. has Antiapoptotic Effects in Prostate Cancer Docimo, M.D. and is Elevated in Primary and Metastatic Prostate Malignancies University of Pittsburgh, Pittsburgh, PA, USA. Ardavan Akhavan, BA, Uzma S. Shah, 1:46 p.m. 21. Another Benefit of Laparoscopy for Ph.D., Anil Parwani, M.D., Joel B. Nelson, Non-palpable Testes: Finding Contralateral M.D., Beth R. Pflug, Ph.D. Hernias University of Pittsburgh, Pittsburgh, PA, USA. Bulent Onal, M.D., Barry A. Kogan, M.D., P32. F.A.C.S., F.A.A.P. 3:14 p.m. Safety and Efficacy of Bladder Botulinum Toxin Injection in the Elderly Albany Medical College, Albany, NY, USA. Marc C. Smaldone, M.D.1, Margie O’Leary, 1:53 p.m. 22. Anticholinergic Effects on Short-term M.S.N, R.N1, Catherine A. Thomas, Ph.D.1, Memory Recall Janet Erickson, B.S.1, Sara Marx, B.S.1, Barry A. Kogan, M.D.1, Karla M. Giramonti, Christopher P. Smith, M.D.2, Michael B. MS FNP1, Leslie F. Halpern, Ph.D2. Chancellor, M.D.1 1The Urological Institute of Northeastern New 1University of Pittsburgh Medical Center, York, Albany, NY, USA, 2University at Albany, Pittsburgh, PA, USA, 2Baylor College of SUNY Department, Albany, NY, USA Medicine, Houston, TX, USA. 2:00 p.m. Adjourn 3:17 p.m. P33. Ureteroscopic Treatment of Stone Disease is Equally Effective in Both Younger 2:00 – 4:00 p.m. Moderated Poster Session III— and Older Pediatric Populations Pediatrics, Female Urology, Basic Marc C. Smaldone, M.D., Glenn M. and General Urology Cannon, Jr., M.D., Jeffrey Bassett, Hsi- Moderators: Robert Lai, M.D. Yang Wu, M.D., Mark F. Bellinger, M.D., Ross G. MacMahon, M.D. Steven G. Docimo, M.D., Francis X. At the conclusion of this session, participants will be able to: Schneck, M.D. • Describe current areas of research in pediatric urology, and state-of- University of Pittsburgh Medical Center, the-art therapeutic options for managing patients with common and Pittsburgh, PA, USA. complex pediatric urological problems. • Describe treatment options for urinary incontinence with emphasis on 3:20 p.m. P34. Bone Marrow Derived Cells (BM.D.Cs) surgical procedures and therapeutic outcomes. are Capable of Regenerating Prostate • Describe current research in prostate cancer. Epithelium: Implications for an Extra-prosta- • Identify safety and tolerability of different pharmacological therapies tic Source of Prostate Progenitor Cells 1 in a urological disorders Ganesh S. Palapattu, M.D. , Alan Meeker, Ph.D.2, Timothy Harris, BS 2, Michael 2:00 – 2:30 p.m. Guest Lecture: Pediatric Urology Collector, MS 2, Saul Sharkis, Ph.D.2, Curtis A. Sheldon, M.D. Angelo DeMarzo, M.D., Ph.D.2, Charles 2 2:30 – 3:00 p.m. Break — Visit Exhibit Hall Drake, M.D., Ph.D. , William G. Nelson, M.D., Ph.D.2 3:00 – 3:30 p.m. Stump the Professors 1University of Rochester School of Medicine, Difficult Cases from the Community Rochester, NY, USA, 2Johns Hopkins University Michael O. Koch, M.D., Peter R. Carroll, School of Medicine, Baltimore, MD, USA. M.D., Dean G. Assimos, M.D., Leonard Gomella, M.D. 3:23 p.m. P35. Initial Experience with the Male Sling Using Composite Graft for Treatment 3:00 p.m. Welcome and Introductions of Stress Urinary Incontinence in Post- prostatectomy Patients 3:05 p.m. P29. Intravaginal Testicular Torsion: Bashar Omarbasha, M.D., Oleg Shapiro, Avoiding Neglect of the Infant and Child M.D. Robert Mevorach, M.D., William Hulbert, Upstate Medical University, Syracuse, NY, USA. Ronald Rabinowitz. University of Rochester, Rochester, NY, USA.

3:08 p.m. P30. Early Versus Late Treatment of Voiding Dysfunction with Pelvic Neuromodulation 21

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ 3:26 p.m. P36. The Cost-effectiveness of Suburethral Naeem Bhojani, M.D., Felix K.-H. Chun, Male Sling for Stress Urinary Incontinence Alberto Briganti, Shahrokh F. Shariat, Versus Artificial Urinary Sphincter 800 Francois Bénard, Claus G. Roehrborn, Oleg Shapiro, M.D., Bashar Omarbasha, Markus Graefen, Hartwig Huland, Pierre I. M.D. Karakiewicz. Upstate Medical University, Syracuse, NY, USA. University of Montreal Health Center, Montreal, PQ, Canada. 3:29 p.m. P37. Sildenafil Citrate (Viagra®) is Efficacious and Well Tolerated in Men with 3:47 p.m. P43. The Tolerability of Tolterodine is Not Both Erectile Dysfunction and Lower Diminished in Older Patients: An Analysis Urinary Tract Symptoms of 5 Randomized, Double-blind, Placebo- Evan R. Goldfischer, M.D.1, Kevin T. controlled Trials McVary, M.D.2, Li-Jung Tseng, PhD3, Gené Evan R. Goldfischer, M.D.1, Dale B. Glasser, van den Ende, MBBCh3. Ph.D.2, Martin Carlsson, MS 2. 1Hudson Valley Urology, P.C., Poughkeepsie, NY, 1Hudson Valley Urology, P.C., Poughkeepsie, NY, USA, 2Feinberg School of Medicine, USA, 2Pfizer, Inc, New York, NY, USA. Northwestern University, Chicago, IL, USA, 3:50 p.m. P44. HATS—Health Advocacy in Training 3Pfizer Inc, New York, NY, USA. Survey 3:32 p.m. P38. Ureteral Access Sheath Usage in Mike Leveridge, Darren Beiko, D. Robert Pediatric Ureteroscopy Siemens. Glenn M. Cannon, Jr., M.D., Marc C. Queen’s University, Kingston, ON, Canada. Smaldone, M.D., Jeffrey C. Bassett, BS, P45. Hsi-Yang Wu, M.D., Mark F. Bellinger, 3:53 p.m. Genotyping of SRA Isoforms in the M.D., Steven G. Docimo, M.D., Francis X. Caucasian Prostate Cancer Patients Shozo Sugita1, Ching Y. Wang1, Tomoaki Schneck, M.D. Tanaka2, Hidenori Kawashima2, Tatsuya Children’s Hospital of Pittsburgh, Pittsburgh, PA, Nakatani2, Gabriel P. Haas1. USA. 1SUNY Upstate medical university, Syracuse, NY, 3:35 p.m. P39. Short-term Independent Outcomes USA, 2Osaka City University graduate school of with the Prolieve Thermodilation System for Medicine, Osaka, Japan. BPH 3:30 – 4:00 p.m. Podium Session IV—Prostate Cancer William P. Conners, III, M.D., Ronald P. Recurrence/Biopsies Kaufman, Jr., M.D., Badar M. Mian, M.D., Moderators: Badar Mian, M.D. Hugh A. G. Fisher, M.D. At the conclusion of this session, participants will be able to: Albany Medical College, Albany, NY, USA. • Describe areas of clinical research in prostate cancer, and identify 3:38 p.m. P40. Progression of Prostate Carcinogenesis areas of controversy in the treatment of prostate cancer patients. in an ERCC1-deficient Prostatic Tissue • Identify recent developments in the clinical and pathological staging Recombinant Model of prostate cancer. Derek J. Matoka, M.D., Veronica Yao, • Describe pharmacological and surgical options for treating patients Ph.D., Dean J. Bacich, Ph.D. with different stages of prostate cancer. University of Pittsburgh, Pittsburgh, PA, USA. 3:30 p.m. 23. Prostate Volume and High Grade 3:41 p.m. P41. The Importance of Pressure-Flow Study Prostate Cancer: Are Pcpt Findings Right? for Predicting Postoperative Voiding Vincent Fradet Fradet, M.D., Alberto Difficulties in Women with Stress Urinary Briganti, Felix K.-H. Chun, Francesco Incontinence: A Preliminary Study that Montorsi, Markus Graefen, Hartwig Correlates Low Pdet x Qave Value with Huland, Pierre I. Karakiewicz. Postoperative Residual Urine University of Montreal Health Center, Montreal, Hidenori Kawashima, M.D., Ph.D. PQ, Canada. Osaka City University Graduate School of 3:37 p.m. 24. Number of Positive Cores Does Not Medicine, Osaka, Japan. Improve Ability in Predicting Pathological 3:44 p.m. P42. BMI and Its Ability to Improve Stage and Biochemical Recurrence (BCR) Prediction of Biochemical Recurrence (BCR) Thierry Lebeau, M.D., Alberto Briganti, After Radical Prostatectomy (RP): Does a Felix K.-H. Chun, Markus Graefen, Statistically Significant Marker Always Francesco Montorsi, Patrizio Rigatti, Improve Predictive Accuracy in Multivariate Hartwig Huland, Pierre I. Karakiewicz. Models? University of Montreal Health Center, Montreal, PQ, Canada. 22

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING 3:44 p.m. 25. Prostate Volume at Initial Biopsy is the 8:05 a.m. 27. Retroperitoneoscopic Live Donor Most Important Predictor of Repeat Biopsy Nephrectomy: Initial Experience with a Outcome: Validation of a Novel Predictive Modiﬁed Hand-assist Approach Tool Andrew Feifer, M.D.1, Abrar Khan, M.D.2, Alvaro Ramirez, M.D., Felix K.-H. Chun, Jean Tchervenkov, M.D.1, Mark K. Plante, Alberto Briganti, Christopher Porter, M.D.2, John-Paul Capolicchio, M.D.1. Francesco Montorsi, Markus Graefen, 1McGill University, Montreal, PQ, Canada, Patrizio Rigatti, Hartwig Huland, Pierre I. 2University of Vermont, Burlington, VT, USA. Karakiewicz. University of Montreal Health Center, Montreal, 8:12 a.m. 28. Robot-assisted Radical Prostatectomy in PQ, Canada. Obese Patients Judd Boczko, M.D., Seth Capello, M.D., 3:51 p.m. 26. Impact of Gland Size on Initial 10 or Dragan Golijanin, M.D., Ralph Madeb, More (+) Core Prostate Biopsy: M.D., Hiten Patel, M.D., Jean V. Joseph, Development and Internal Validation of a M.D. 10+ Cores Biopsy Nomogram Strong Memorial Hospital, University of Vincent Cloutier, M.D., Alberto Briganti, Rochester, Rochester, NY, USA. Felix K.-H. Chun, Shahrokh F. Shariat, Markus Graefen, Francesco Montorsi, 8:19 a.m. 29. Location of Positive Margin and PSA Patrizio Rigatti, Claus G. Roehrborn, Progression in Patients Undergoing Hartwig Huland, Pierre I. Karakiewicz. Extraperitoneal Robot-assisted Radical University of Montreal Health Center, Montreal, Prostatectomy PQ, Canada Judd Boczko, M.D., Seth Capello, M.D., Dragan Golijanin, M.D., Jorge Yao, Ralph 4:00 p.m. Adjourn Madeb, M.D., Erdal Erturk, M.D., Hiten Patel, M.D., Jean V. Joseph, M.D. 4:00 – 4:30 p.m. Guest Lecture: Prostate Cancer Strong Memorial Hospital, University of Peter R. Carroll, M.D. Rochester, Rochester, NY, USA.

4:30 – 5:15 p.m. Strategic Retirement and Estate Planning 8:26 a.m. 30. Early Potency Outcomes After Cautery- Solutions free Versus Bipolar Neurovascular Bundle Joel M. Blau, CFP, Mediqus Asset Advisors, Preservation During Extraperitoneal Robotic Inc. (spouses invited) Prostatectomy 7:00 – 11:00 p.m. Fun Night — Canadian War Museum Judd Boczko, M.D., Seth Capello, M.D., Mary Mathe, PA, Erdal Erturk, M.D., Hiten Patel, M.D., J V. Joseph, M.D. SATURDAY, SEPTEMBER 9, 2006 Strong Memorial Hospital, University of Rochester, Rochester, NY, USA. 6:15 – 9:00 a.m. 5K Fun Run — Rideau Canal 8:33 a.m. 31. Robot-assisted Anterior Exenteration: 6:45 – 7:45 a.m. Residents’ Breakfast Session Technique and Case Series Nikhil Shah, M.D. Mark A. Nogueira, M.D.1, Hyung L. Kim, 7:00 – 8:00 a.m. Annual Business Meeting M.D.2, Pamela Piacente, PA2, Gregg E. Zimmerman, M.D.2, James L. Mohler, 8:00 – 9:00 a.m. Podium Session V — Laparoscopy M.D.2, Khurshid A. Guru, M.D.2. Moderators: David A Corral, M.D. 1State University of New York at Buffalo, Stephen E. Pautler, M.D. Buffalo, NY, USA, 2Roswell Park Cancer Institute, At the conclusion of this session, participants will be able to: Buffalo, NY, USA. • Describe current alternatives in surgical treatments for patients with kidney and bladder stones. Identify state-of –the –art surgical techniques 8:40 a.m. 32. Intermediate Term Follow up of in the management of different Urological disorders using laparoscopy. Laparoscopic Renal Tumor Cryoablation: • Describe current alternatives in surgical treatments for patients with Proceed with Caution kidney and bladder stones. Gregory Spana, M.D., Amar Singh, M.D., Bijan Shekarriz, M.D., Alireza Moinzadeh, 8:00 a.m. Welcome and Introductions M.D. SUNY— Upstate Medical University, Syracuse, NY, USA.

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ 8:47 a.m. 33. Laparoscopic Extravesical Ureteral A Review of Clinical Experience Reimplantation: Initial Experience with Two James M. Belarmino, M.D.1, Michael Cases Perrotti, M.D.2. Margaret Roth, M.D., Amar Singh, Ali 1Albany Medical Center, Albany, NY, USA, 2St. Moinzadeh, M.D. Peters Hospital, Albany, NY, USA. SUNY-Upstate Medical University, Syracuse, NY, USA. 9:23 a.m. P52. Preoperative and Intraoperative Imaging of Penile Sentinel Lymph Nodes 8:54 a.m. Discussion (SLN) Using Indocyanine Green (ICG) Near Infrared Fluorescence (NIRF) 9:00 a.m. Adjourn Dragan Golijanin, M.D., Ralph Madeb, 9:00 – 10:00 a.m. Moderated Poster Session IV— M.D., Ronald Wood, Ph.D., Jay E. Reeder, Other Cancer Ph.D., Vikram Dogra, M.D., Jorge Yao, Moderators: Ronald P. Kaufman, M.D. M.D., Jean Joseph, Edward M. Messing, At the conclusion of this session, participants will be able to: M.D. • Describe current areas of research in Urologic cancers. Department of Urology, Pathology and • Identify areas of controversy in treating patients and state-of-the-art Radiology, URMC,SMH, Rochester, NY, USA. therapeutic options for managing patients with common and complex 9:26 a.m. P53. Intraoperative Sentinel Lymph Node urological problems. (SLN) Detection Using Near Infrared 9:00 a.m. Welcome and Introductions Fluorescence (NIRF) After Intravesical Indocyanine Green (ICG) Administration to 9:05 a.m. P46. Effect of Perioperative Blood Up II / SV 40T Mouse Model of Bladder Transfusion on Prostate Cancer Recurrence Cancer Satish Sharma, M.D.2, James Mohler, M.D.2 Dragan Golijanin, M.D., Aimee Johnson, Beneranda S. Ford, M.D.1 MS, Jay E. Reeder, Ph.D., Ronald Wood, 2Roswell Park Cancer Institute, Buffalo, NY, USA., Ph.D., Vikram Dogra, M.D., Jean Joseph, 1SUNY @ Buffalo, Buffalo, NY, USA M.D., Edward M. Messing, M.D. Departments of Urology, Pathology and 9:08 a.m. P47. Single-centre Evaluation of the NMP-22 Radiology, URMC,SMH, Rochester, NY, USA. Point-of-care Assay as an Adjunctive Tool for the Diagnosis of Bladder Cancer 9:29 a.m. P54. The Effect of Competing Mortality on Sylvia M. Robb, RN, Research Coordinator, the Risk of Cancer-speciﬁc Survival in Kidney Laurel Emerson, RN Research Coordinator, Cancer Chris Kong, Medical Student, Alvaro Quoc-Dien Trinh, M.D., Pierre I. Morales, M.D. FRCSC. Karakiewicz, Paul Perrotte, Alberto Briganti, Queens University, Kingston, ON, Canada. Felix K.-H. Chun, Jean-Jacques Patard University of Montreal Health Center, Montreal, 9:11 a.m. P48. Observation of Large Renal Masses: PQ, Canada. Insight into the Natural History of Kidney Cancers 9:32 a.m. P55. Internal Validation of a Competing- Ashley R. Cox, M.D., Joseph L. Chin, M.D., Risks Survival Nomogram for Patients Stephen E. Pautler, M.D. Treated with Radical Prostatectomy (RP) for University of Western Ontario, London, ON, Clinically Prostate Cancer (PCa). Canada. Quoc-Dien Trinh, M.D., Christopher Porter, Alberto Briganti, Felix K.-H. Chun, Pierre I. 9:14 a.m. P49. Post-prostatectomy Incontinence: Karakiewicz. Factors Affecting Treatment Success University of Montreal Health Center, Montreal, Paul H. Johnston, M.D., D. Robert Siemens, PQ, Canada. M.D., Janice Jackson, R.N. Queen’s University, Kingston, ON, Canada. 9:35 a.m. P56. The Effect of Competing Mortality on Prostate Cancer (PCa)-speciﬁc Survival and 9:17 a.m. P50. Evaluation of a Novel Technique of Rate of Metastatic Disease after Radical Running Fascial Closure and Post-operative Prostatectomy (RP) Incisional Hernia in 245 Consecutive Open Christopher Porter, M.D., Alberto Briganti, and Laparoscopic Urologic Surgical Felix K.-H. Chun, Koichi Kodama, Robert Procedures Gibbons, Roy Jnr. Correa, Paul Perrotte, 1 James M. Belarmino, M.D. , William Pierre I. Karakiewicz. 1 2 Badger, M.D. , Michael Perrotti, M.D. . University of Montreal Health Center, Montreal, 1Albany Medical Center, Albany, NY, USA, 2St. PQ, Canada. Peters Hospital, Albany, NY, USA. 24 9:38 a.m. P57. The Birt-Hogg-Dube Tumor Suppressor 9:20 a.m. P51. Snowboarding and Blunt Renal Trauma:

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING is Predominantly Localized in the Nucleolus At the conclusion of this session, participants will be able to: and Regulates IFn-y Induced JAK-STAT1- • Describe areas of clinical research in calculus disease. ISRE Pathway • Describe current alternatives in the surgical treatment for patients with Dakun Wang, Ph.D., Edward M. Messing, with kidney and ureteral stones in the adult and pediatric population. M.D., Guan Wu, M.D., Ph.D. • Identify factors affecting outcomes in different urological cancers. University of Rochester, Rochester, NY, USA. 10:00 a.m. Welcome and Introductions 9:41 a.m. P58. Management of Bilateral Synchronous Renal Cell Carcinoma in a Single Procedure 10:05 a.m. 34. Cross-Sectional Area: A Novel Predictor Bruce L. Jacobs, M.D., Erin P. Gibbons, of Ureteral Stone Outcome Kirk Roth, BScH 2001, James Wilson, M.D., M.D., Ronald L. Hrebinko, M.D. Paul Johnston, M.D. University of Pittsburgh Medical Center, Queen’s University, Kingston, ON, Canada. Pittsburgh, PA, USA. 10:12 a.m. 35. The Ureteroscopic Management of 9:44 a.m. P59. The Effect of Competing Mortality on The Risk of Bladder Cancer Recurrence and Nephrolithiasis: 5-year Experience in a Bladder Cancer-speciﬁc Survival Pediatric Institution Marc C. Smaldone, M.D., Glenn M. Thierry Lebeau, M.D., Felix K.-H. Chun, Cannon, Jr., M.D., Jeffrey Bassett, Ethan Alberto Briganti, Shahrokh F. Shariat, Polsky, M.D., Hsi-Yang Wu, M.D., Mark F. Arthur I. Sagalowsky, Seth P. Lerner, Mark Bellinger, M.D., Steven G. Docimo, M.D., Schoenberg, Pierre I. Karakiewicz. Francis X. Schneck, M.D. University of Montreal Health Center, Montreal, University of Pittsburgh Medical Center, PQ, Canada. Pittsburgh, PA, USA. 9:47 a.m. P60. The Von Hippel-Lindau Tumor Suppressor Interacts with Receptor for 10:19 a.m. 36. The Ureteroscopic Management of Activated C Kinase 1 and Represses Insulin- Lower Pole Stones in a Pediatric Population Like Growth Factor I-induced Renal Glenn M. Cannon Jr., M.D., Marc C. Carcinoma Cell Invasiveness Smaldone, M.D., Jeffrey Bassett, Hsi-Yang Wu, M.D., Mark F. Bellinger, M.D., Steven Guan Wu, M.D., Ph.D. G. Docimo, M.D., Francis X. Schneck, M.D. Medical Center, UR, Rochester, NY, USA. University of Pittsburgh Medical Center, 9:50 a.m. P61. Development and External Validation of Pittsburgh, PA, USA. Nomograms Predicting Necrosis vs. Teratoma vs. Residual Cancer at Post-chemotherapy 10:26 a.m. 37. Staged Retrograde Endoscopic Resection of Residual Masses Lithotripsy as an Alternative to PCNL in Pierre I. Karakiewicz, M.D., Paul Perrotte, Select Patients with Large Renal Calculi Daniel Ricchiuti, M.D.1, Benjamin Stockton, Yvonne Vergrouwe, Ewout W. Steyerberg. M.D.1, Marc Smaldone, M.D.1, Bruce University of Montreal Health Center, Montreal, Jacobs1, Arlene Smaldone, MPH2, Stephen PQ, Canada. Jackman, M.D.1, Timothy Averch, M.D.1 9:53 a.m. P62. Renal Preservation Following Partial 1University of Pittsburgh, Pittsburgh, PA, USA, Nephrectomy as Measured by Creatinine 2Columbia University, New York, NY, USA Clearance Aaron T. D. Clark, M.D., Kunal Jana, M.D., 10:30 a.m. Adjourn Chris Morash, M.D., Ilias Cagiannos, M.D. 10:30 – 11:00 a.m. Guest Lecture: Surgical Management of University of Ottawa, Ottawa, ON, Canada. Patients with Complex Nephrolithiasis 10:00 a.m. Adjourn Dean G. Assimos, M.D. 9:00 – 9:30 a.m. Slotkin Lecture —Computer Assisted 11:00 – 11:30 a.m. Guest Lecture Robotic Surgery (CARS): A Paradigm Shift Interstitial Cystitis: Update on Pathology After 2600 Cases and Treatment Grannum R. Sant, M.D. Mani Menon, M.D. 9:00 a.m.– 12:00 p.m. Exhibit Hall Open 11:30a.m.–12:15p.m. U.S.-Canadian Socioeconomics Update 9:30 – 10:00 a.m. Break — Visit Exhibit Hall 12:30 – 5:30 p.m. Golf Tournament — Chateau Cartier Resort 10:00 – 10:30 a.m. Podium Session VI — Stones 1:15 – 4:30 p.m. Tennis — The Ottawa Athletic Club Moderators: Erdal Erturk, M.D. 1:15 – 3:00 p.m. Tours — Options Hassan Razvi, M.D. 25

FRIDAY, SEPTEMBER 8, 2006 SATURDAY, SEPTEMBER 9, 2006 7:30 – 8:00 a.m. Breakfast 7:30 – 8:00 a.m. Breakfast 8:10 – 8:30 a.m. Welcome 8:00 – 9:00 a.m. Education Session (1 CEU) Gabriel P. Haas, M.D., Female Sexual Dysfunction Northeastern Section of the AUA, President Bashar Omarbasha, M.D. Medical Director, Susan Freed, R.N., CNY Male Sexual Diagnostic Center, Urology Nurses of Canada, President Oneida, NY Clinical Instructor, Department Susan Lipsy, R.N., M.S., C.U.N.P., of Urology, SUNY Upstate Medical Society of Urologic Nurses and Associates, University, Syracuse, NY Northeast, Regional Director Moderator: Kevin Hiscock, R.T.R. 8:30 – 9:55 a..m. Education Session (1 CEU) 9:00 – 9:30 a.m. Guest Lecture Interstitial Cystitis: Past, Present and Future New Paradigms in Treatment of BPH Vicki Ratner, M.D. Grannum R. Sant, M.D. President and Chief Medical Ofﬁcer, The Interstitial Cystitis Association 9:30 – 10:00 a.m. Break — Visit Exhibit Hall Moderator: Amy LoPresti, R.N. 10:00 – 11:00 a.m. Education Session (1 CEU) 10:00 – 10:15 a.m. Morning Break Erectile Dysfunction — Current Evaluation and Management 10:15 – 11:30 a.m. Education Session (1 CEU) Jonathan D. Block, M.D., Ph.D., M.B.A., Vesicoureteral Reﬂux: Is There a New P.F.P.M. Vice-President and Partner, Perspective? Mohawk Valley Urology, PC Chair, Jyoti Upadhyay, M.D., F.A.A.P. Chief, Department of Urology, Faxton-St. Luke’s Division of Pediatric Urology Director of Healthcare, Utica, NY Pediatric Urology SUNY Upstate Medical Moderator: Susan Lipsy, R.N., M.S., C.U.N.P. University, Syracuse, NY. Moderator: Nancy Bauer, R.N. 11:00 a.m.–12:30p.m. Education Session (1.5 CEU) Comparison of Current Treatment Strategies 11:30 a.m.–1:30 p.m. Lunch — Exhibit Hall for Overactive Bladder, Urge Urinary Incontinence and Female Stress Urinary 1:30 – 2:45 p.m. Education Session (1.5 CEU) Incontinence in Canada and the United States GU Pathology (Why are they having a Kevin Victor Power, H.B.A., M.D., F.R.C.S.C. pathologist talk?) Attending Urologist, Queensway Carleton Steve K. Landas, M.D. Departments of Hospital, Ottawa, Canada, Robert S. Lai, Pathology and Urology SUNY Upstate M.D. Director of Urodynamics, Neurology, Medical University, Syracuse, NY. and Female Urology Assistant Professor, Moderator: Gina Brothers, R.N., N.P. Department of Urology, SUNY Upstate 2:45 – 3:15 p.m. Afternoon Break Medical University, Syracuse, NY. Moderator: Oleg Shapiro, M.D. 3:15 – 4:15 p.m. Education Session (1 CEU) Ask Your Colleagues : Management of Adult Total: 3.5 CEUs and Pediatric Enuresis, Obstructive Uropathy and Urinary Tract Infections Exhibit Hall Hours Panel: Gina Brothers, R.N., N.P., Susan Thursday, September 7, 2006 Lipsy, R.N., M.S., C.U.N.P., Lisa Lynch, R.N., O.N.C., Maryellen Sheridan, R.N., M.S., 11:30 a.m.–1:00 p.m. Sneak Peek Luncheon Frances Stewart, R.N., N.C.A. Moderator: Amy LoPresti, R.N. 5:30–7:00 p.m. Grand Opening Welcome Reception Total : 4.5 CEUs Friday, September 8, 2006 10:00 a.m.– 3:00 p.m. Saturday, September 9, 2006 9:00 a.m.–12:00 p.m.

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Social Event Information: Dine Around

THURSDAY, SEPTEMBER 7, 2006 BUSINESS CASUAL—MID-RANGE RESTAURANTS The following restaurants are currently holding spots for the Empire Grill dine around evening. Please review the list of restaurants and 20 spots reserved choose the one that you would like to go to for the dine around this evening. Feel free to visit the web sites for each of these Reservation Time: 7:00 p.m. restaurants to get a better idea of what the restaurant is like and to review their current menus. A price per person for a Eclectic fusion cuisine, specialty is steak. Excellent wine selec- three-course dinner — includes an appetizer, entree and a tion. Great atmosphere — very chic and modern. A popular spot dessert and excludes alcohol — has also been provided as a gen- for locals. eral guide for you. Each restaurant has reserved a limited num- Estimate $35–$65 CDN per person, plus taxes and 15% gratuity ber of spots for our group. However, if there is a high demand for a particular restaurant, we will try our best to accommodate www.empiregrill.com your request. Kinki On the night of the dine around, staff will meet each group and 30 spots reserved (private room) walk them to the restaurant for their reservations. Reservation Reservation Time: 7:30 p.m. times have been booked and are indicated below. Please con- ﬁrm the reservation time for your restaurant upon registration at Asian-fusion food and excellent Sushi selections; including the conference. Once you have arrived at the restaurant, the assorted tasting plates. In-vogue Asian inspired dining lounge staff will depart and you will be on your own for the rest of the sporting clean, modern architecture. evening. Estimate $37–$74 CDN per person, plus taxes and 15% gratuity Guests will be 100% responsible for paying for their own www.kinki.ca meal at the restaurants. Meditheo Mediterranean Restaurant & Bar 20 spots reserved CASUAL RESTAURANTS Blue Cactus Bar & Grill Reservation Time: 7:00 p.m. 24 spots reserved Nouveau-Mediterranean cuisine at an attractive price. An array of food options for sharing appetizers and entrees. Lots of old Reservation Time: 7:30 p.m. brick interior — very cozy and relaxed atmosphere. 2003 LCBO A fun and casual dining experience surrounded by fresh, upscale Golden Glass Award for Best Wine List in Ottawa. International Southwestern décor. Come and enjoy award-winning Margaritas restaurant organizations platinum award. and contemporary Southwestern cuisine. Estimate $32–$73 CDN per person, plus taxes and 15% gratuity Estimate $23–$51 CDN per person, plus taxes and 15% gratuity. www.meditheo.com www.bluecactusbarandgrill.com

The Aulde Dubliner Mezzanotte Italian Bistro 24 spots reserved 20 spots reserved Reservation Time: 7:30 p.m. Reservation Time: 7:00 p.m. Excellent modern Irish-rooted pub with a delicious mix of light Amazing Italian cuisine with a twist of originality. Choose from and hearty fare. Located in the heart of the Byward Market, this their extensive wine list that includes wines from around the restaurant features an expansive view overlooking the market. world. Enjoy great food and great service surrounded by a mod- Come and enjoy the warm and friendly atmosphere. Offers a ern and comfortable atmosphere. kids’ menu. Excellent beer selections. Estimate $26–$60 CDN per person, plus taxes and 15% gratuity Estimate $20–$40 CDN per person, plus taxes and 15% gratuity. www.mezzanotte-bistro.com www.auldedubliner.com 27

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ Milestones Restaurant & Bar Metropolitan Brasserie 20 spots reserved 20 spots reserved Reservation Time: 7:30 p.m. Reservation Time: 7:30 p.m. Offers patrons innovative food, cocktails and great service. Located in the heart of downtown, this Parisien style Brasserie Surrounded by eclectic and relaxed décor—which is stylishly offers guests both excellent cuisine and French Bistro decor. rich in wood and comfort. Signature drink is the “Bellini”’— a Exclusive oyster bar and extensive wine/cocktail list. deﬁnite must! Estimate $25–$79 CDN per person, plus taxes and 15% gratu- Estimate $31–$50 CDN per person, plus taxes and 15% gratuity ity for a three course meal. www.milestonesrestaurants.com www.metropolitainbrasserie.com

UPSCALE RESTAURANTS Social e18hteen 20 spots reserved 24 spots reserved Reservation Time: 7:00 p.m. Reservation Time: 7:00 p.m. Enjoy traditional French and contemporary North American cui- World-fusion cuisine in a beautifully restored historic building. sine within Social’s sumptuous and elegant atmosphere. With its Two-story high ceilings, ﬁreplace and brick walls. Excellent food distinctive architecture and interior décor, Social is a popular spot and wine. for local Ottawatonians. Great food and service. Estimate $41–$62 CDN per person, plus taxes and 17% gratuity Estimate $31–$57 CDN per person, plus taxes and 15% gratuity www.restaurant18.com www.social.ca

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Social Event Information: tOURS

The following tours have been reserved for guests on Friday, Tour Option # 2: Old English Trolley Guided City Tour September 8 and Saturday, September 9, 2006. Each tour group Climb aboard your very own Old English Trolley and enjoy a will be accompanied by a tour director who will meet the group two-hour private tour of Ottawa. With the expert knowledge of in the lobby of the Westin Hotel prior to tour departure. Tour your tour guide, you will be carried through the downtown core, descriptions and times are listed below. Guests are encouraged along Confederation Boulevard (our ceremonial route), past to pre-register for the tours that they would like to participate in monuments and many when they pre-register for the conference, as spots will go of Ottawa’s main quickly. On-site tour registration will take place at the hotel on attractions, including Wednesday, September 6 between 5:00 – 7:00 p.m. and the Museum of Thursday, September 7 between 7:00 a.m. – 4:00 p.m. and will Civilization, the be on a ﬁrst-come, ﬁrst-served basis for any empty spots. National Gallery, Payments can be made on-site at the hotel for any tours that Rideau Hall, the have not been pre-registered and paid for. Supreme Court and much more. There will *Please note that prices include transportation, trip director and be plenty of opportuni- tour/activity costs. If minimum numbers are not met, tours ty for taking pictures. will be cancelled. To learn more about Ottawa, please visit the city’s web site at www.ottawa.ca. FRIDAY, SEPTEMBER 8, 2006 Schedule: Tour Option # 1: Cordon Bleu Cooking Institute 9:30 a.m. Meet trip director in lobby of Westin Ottawa and board bus or trolley Le Cordon Bleu Paris Culinary Arts Institute has evolved from a Parisian Culinary School, established in 1895, to an international 9:45 a.m. Guided city tour begins culinary network with more than 26 schools in 15 countries. For more than a hundred years, people around the world have 11:45 a.m. End of city tour, arrive back at Westin looked to Le Cordon Bleu for “la crème de la crème” in profes- Ottawa sional training in the culinary arts. If you love to cook and you love to eat, then this tour is for you. Join your host for a guided Length of Tour: 2 hours tour of the Culinary Institute, where you can see the chefs at Minimum # per tour: 10 people work. Following your tour, you will be invited to observe a one- hour chocolate cooking demonstration by one of their in-house Maximum # per tour: 30 people chefs. Everyone will be able to sample the results and even take home a few samples, too. Enjoy! Cost: $70 USD per person To learn more about the Cordon Bleu Cooking Institute, please visit their web site at www.cordonbleu.net.

Schedule: 9:00 a.m. Meet trip director in lobby of Westin Ottawa 9:10 a.m. Depart for Cordon Bleu 9:30 a.m. Tour and chocolate cooking demonstration 11:30 a.m. Re-board Bus for return transfer 11:45 a.m. Arrive back at Westin Ottawa

Length of Tour: 2 hours Minimum # of Participants: 20 people Maximum # of Participants: 40 people Cost: $105 USD per person 29

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ Tour Option # 3: Walking Tour of Downtown 1:30 p.m. Acquire bicycles and helmets and and Byward Market meet with their tour guide(s) Accompanied by your very own historically costumed 1:40 p.m. Depart on bicycle tour guide, guests will get a 3:00 p.m. Arrive back at start location, guests return personal tour of the all equipment and walk back to hotel renowned Byward Market. Comprised of many histor- Length of Tour: 2 hours ical buildings and unique shopping venues, the Minimum # per tour: 10 people Byward Market is a won- derful place to explore. Maximum # per tour: 30 people Your two-hour tour will Cost: $35 USD per person include a short walk along the Rideau Canal, a brief stop at the (includes ﬁtting/adjustment, bike, helmet, lock and map) Tomb of the Unknown Soldier, Parliament Hill, Majors Hill Park, the American Embassy and concluding in the Byward Market. Each participant will be given a Beavertail coupon for a Tour Option # 2: Parliament Hill — Centre Block Cinnamon and Sugar Beavertail (a “must try” for anyone visiting Ottawa). A must see for every visitor to the Nation’s Capital, the Parliament buildings are rich in history, architecture and politics. *Please note, tour operates rain or shine, unless heavy thunder- Knowledgeable, bilingual tour guides will lead your group storms. Please be prepared. through the Centre Block, the House of Commons and the Senate, imparting information and answering any questions that To learn more about Ottawa, please visit the city’s web site at the group may have. After the tour, participants are invited to www.ottawa.ca. visit the magniﬁcent Peace Tower and travel to the top for a spectacular view of the city. Schedule: 9:30 a.m. Meet trip director in lobby of Westin Ottawa Schedule: 9:45 a.m. Depart on walking tour 1:15 p.m. Meet trip director in lobby of Westin Ottawa and depart on foot 11:30 a.m. Return to Westin Ottawa 1:30 p.m. Arrive at Parliament Hill, check in with Length of Tour: 2 hours group tours Minimum # per tour: 10 people 1:45 p.m. Private tour of Parliament Hill — Centre Block Maximum # per tour: 25 people 2:30 p.m. End of tour, guests can visit the Peace Tower Cost: $40 USD per person and the gift shop 2:50 p.m. Group departs for return to Westin Ottawa SATURDAY, SEPTEMBER 9, 2006 3:00 p.m. Arrive back at Westin Ottawa

Tour Option # 1: Bicycle Tours Length of Tour: 1 hour Bicycle tours are a great way to see Ottawa. Accompanied by a Minimum # per tour: 10 people knowledgeable tour guide, you are bound to have fun exploring the city by bicycle while receiving a commentary. Two different Maximum # per tour: 50 people guided tours are available: Rockcliffe Park (the only tour in (recommend 25) Ottawa allowed to travel through this exclusive area) or the Cost: $15 USD per person Rideau Canal. Mountain bicycles are available for all age groups. Tour route will be determined on the day of the event. * Please note that, should the House be in session, tours will not operate. Cancellation of tours, due to ofﬁcial functions, could be of very short To learn more about Ottawa, please visit the city’s web site at notice. www.ottawa.ca. To learn more about Parliament Hill, please visit their web site Schedule: at www.parl.gc.ca. 1:15 p.m. Meet trip director in lobby of Westin hotel and walk to bicycle tour location

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Social Event Information

FRIDAY, SEPTEMBER 8, 2006 Fun NigNightht Canadian War Museum 7:00 – 11:00 p.m. Welcome to Ottawa’s newest museum, the Canadian War Museum. This museum is a culmination of many minds and is a tribute to all of our citizens who ever participated in a war. For those guests who would like to have a costume and/or acces- Designed to look like a bunker from the outside, the Canadian sories for this event, we have a number of options to choose from: War Museum offers a number of fascinating exhibits inside that will truly tell the tale of the wars fought and won…and lost. In Men: addition to entertainment, the Museum exhibits will be opened • zoot suits (green, navy, charcoal or blue) for guests to wander through on self-guided tours throughout • fedoras, pocket watches (rented individually) the evening, with Museum guides located in each of the four • accessory package (Fedora, white tie, black shirt @ $30 CDN exhibit sections to answer any questions that you may have. + GST each) • vintage military dress (will fit smaller men only) Tonight, come and spend a fun night in your exclusive 1940’s • military dress (not specific to 1940s era) “Officer’s Club.” From delicious food, great ambiance and • tuxedos with tails excellent entertainment, tonight is sure to be a night to remember! Relax with your colleagues on comfortable couches Women: and Boogie Woogie with a real swing band. Eat at leisure at • vintage ballgowns (will fit smaller women only) the mouth-watering buffet stations. Sidle up to the bar for a • ballgowns taste of 1940s cocktails. And explore the many vehicles of war • lady’s suits in the numerous displays throughout the Lebreton Gallery. It is • boas, tiaras, long gloves, hats, purses (rented individually) all here for you to enjoy! • accessory package (boa, tiara, long gloves @ $30 CDN + GST each) Costumes are optional and can be rented on-site, if desired. If guests order a costume, accessories are included. However, Or . . . if you were a member of the armed services of either they also have the option of just ordering the accessories (indi- Canada or the United States, pull out your old uniform, polish vidually or as a package) to augment their own outfit. off your medals, head out to the dance floor and do the jitter- bug, the shim sham or the lindy hop! Cost: Costume Details The cost for each costume ranges from $75 CDN and upwards, depending upon the costume that is rented and whether or not For the Officer’s Club evening at the Canadian War Museum on it is vintage. If guests have a budget, the costume house will be Friday, September 8, 2006, any of your guests who would like able to put something together for them within their budget. to have a costume for the evening have a few options to choose from: ** Please note that 8% PST and 6% GST will apply to all costume rentals and purchases. 1) Bring their own costume with them Notes: 2) Pre-order a costume and/or accessories prior to arrival in 1) In order to ensure the best possibility of costume availability, guests will need to Ottawa — best option pre-order their costumes. This can be done directly through Delightful Fancies & Treasures. Phone: 613 238-2058 or e-mail: [email protected] 3) Order a costume and/or accessories on-site upon arrival Contact Person: Aimée. There will be no guarantee of availability of costumes. They (Please note that this option will not guarantee that a costume will be rented on a first come, first served basis. or accessories will be available) 2) All costumes will be delivered to the hotel the morning of Friday, September 8, 2006 and picked up from the hotel as of 10:00 a.m., Saturday, September 9, A Bit of Background on the 1940’s Clothing Era… 2006. Guests will need to ensure that all costumes are returned to the registration desk prior to 9:30 a.m. on Saturday, September 9. During this time, both men and women were smaller than they are today. As such, many of the vintage costumes from the 3) Guests will be invoiced directly for the costume rental by Delightful Fancies & 1940s (e.g., military dress, women’s ballgowns) are only avail- Treasures. They accept Visa, MasterCard, AMEX, Interac and cash. able in smaller sizes for both men and women. However, cos- A representative from the costume house can be on-site during part of the regis- tumes that are not vintage era, but are representative of the tration hours on September 6 and 7 and will be able to take last minute orders 1940s, especially when matched with the appropriate acces- and have sample costumes on-site for guests to see. sories, are available in many different sizes. NOTE: Drinking age at the Canadian War Museum is 19 Popular dress during this time included military uniforms, zoot years. There will be no exceptions. suits, tuxedos with tails, women’s long ballgowns and the short- er knee-length skirt/jacket/blouse and/or pants for women. To learn more about the Canadian War Museum, please visit 31 Small hats, sequined bags, fedoras, boas, etc. were also used to their web site at www.warmuseum.ca. dress up the outfit.

5K Fun Run Golf Tournament 6:15 – 9:00 a.m. 12:30 – 5:30 p.m. Rideau Canal CHATEAU CARTIER RESORT For those avid joggers and This afternoon, guests are invited to par- runners, this morning is for ticipate in a golf tournament at one of you! Come and join your Ottawa’s most beautiful golf courses, colleagues on an early nestled along the banks of the Ottawa morning Fun Run along River. Foursomes will tee off back to the banks of the Rideau back, with nine-minute intervals. Tee off Canal. Please pick up your times will be allocated on a first-come, race packages from the registration desk upon arrival at the first-served basis. Please indicate on conference. Prizes will be given to the top three male and your registration form your handicap and who you would like female runners. Race begins promptly at 7:00 a.m. for runners; to golf with; otherwise, we will create the foursomes. Prizes will 7:10 a.m. for walkers. be given out for a number of different competitions; including closest to the pin, best overall score (male and female), longest To learn more about the Rideau Canal, please visit drive and longest putt. www.ottawa.ca. You will find information about the Rideau Canal under “Attractions” under the Visiting Ottawa drop Guests are invited to bring their own golf clubs or to rent from down menu. the golf course (please indicate if you require right- or left-handed clubs). Electric carts will also be provided for every pair of golfers. Tennis Please pick up your information packages for the golf tournament 1:15 – 4:30 p.m. from the registration desk when you arrive for the conference.

THE OTTAWA ATHLETIC Note: For those guests who are bringing their golf clubs, your clubs will CLUB be transported to the golf course between 8:30 – 10:00 a.m. on The Ottawa Athletic Club is a won- Saturday, September 9. As such, all golf clubs must be tagged with derful facility that plays host to both your name when they are dropped off. Tags will be provided for those indoor and outdoor tennis courts — who do not have a name tag for their golf bag. some of the nicest in the city. This To learn more about the Chateau Cartier Resort and Golf afternoon, you will participate in a Course, please visit their web site at www.chateaucartier.com. tennis game. Rackets and tennis balls can be rented. Transportation is on your own. Tennis courts have been reserved.

Schedule: 1:15 p.m. Meet trip director in lobby of Westin Hotel 1:30 p.m. Depart hotel for Ottawa Athletic Club via taxi (transportation costs not included) 1:45 p.m. Arrive at club 2:00 p.m. Game begins 4:00 p.m. Game ends 4:15 p.m. Depart Ottawa Athletic Club and return to hotel 4:30 p.m. Arrive back at Westin hotel To learn more about the Ottawa Athletic Club, please visit their web site at www.ottawaathleticclub.com.

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING 33

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ Exhibitor listing (alpha) Company Booth No. Company Booth No. Abbott Laboratories 311 Boehringer Ingelheim Pharma, Inc. 312 8401 TransCandada Highway 900 Ridgebury Road St. Laurent PQ H4S 1Z1 Canada Ridgefield, CT 06877 www.abbott.com www.boehringer-ingelheim.com American Kidney Stone Management, Ltd.307 Boehringer Ingelheim Pharma, Inc. is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and a member of the 100 W. Third Avenue, Suite 350 Boehringer Ingelheim group of companies. The Boehringer Columbus, OH 43201 Ingelheim group is one of the world’s 20 leading pharmaceuti- www.aksm.com cal companies. Headquartered in Ingelheim, Germany, it oper- Auxilium Pharmaceuticals, Inc. 502 ates globally with 152 affiliates in 45 countries and more than 34,000 employees. Since it was founded in 1885, the family- 40 Valley Stream Parkway owned company has been committeed to researching, devel- Malvern, PA 19355 opoing, manufacturing and marketing novel products of high www.auxilium.com therapeutic value for human and veterinary medicine. Please visit our exhibit to discuss the latest clinical information on: American Medical Systems 304 Flomax® (tamsulosin hydrocheloride) 10700 Bren Road West Minnetonka, MN 55343 Boston Scientific Corporation 504 www.AmericanMedicalSystems.com 100 Boston Scientific Way Marlborough, MA 01752 American Medical Systems is a world leader in medical devices www.bostonscientific.com and procedures that treat three major diseases: incontinence, erectile dysfunction and benign prostate hyperplasia. Any one of Cook Urological 107 these conditions can profoundly diminish a patient’s quality of life and significantly impact relationships. Our products provide 1100 West Morgan Street a cure or reduce the incapacitating effects of these diseases, Spencer, IN 47460 often through minimally invasive surgery. www.cookurological.com Astellas Pharma US, Inc. 102 A recognized leader worldwide, Cook Urological develops and manufactures products for endourology, ureteroscopy and Three Parkway North incontinence management/treatment. Product lines include: Deerfield, IL 60015 ureteral stents and catheters, stone manipulation devices, dila- www.us.astellas.com tors and access sheaths, wire guides and urethral slings. VESIcare® (solifenacin succinate) is a competitive muscarinic The latest product innovations include; Stratasis® TF Tension Free receptor antagonist and is indicated for the treatment of over- Urethral Sling, for surgical treatment of SUI, Flexor® Ureteral active bladder with symptoms of urge urinary incontinence, Access Sheath, NCompass® Nitinol Stone extractors, and the urgency and urinary frequency. Ascend™ Ureteral Balloon Dilator. Aureon Laboratories 209 Dendreon Corporation 112 28 Wells Avenue 3005 1st Avenue Yonders, NY 1070 Seattle, WA 98121 www.prostatepx.com www.dendreon.com Aureon Laboratories’ Prostate Px™ for prostatectomy tissue and Prostate Px™ utilizing biopsy samples stratify patient risk DiagnoCure Inc. 306 and predict disease severity. Aureon’s Systems Pathology plat- 2050 W. Rene-Levesque Boulevard West, 6th Floor form integrates histology, molecular markers, clinical features, Saint-Foy QE G1V 2K8 Canada advanced image analysis and mathematics to provide a person- www.diagnocure.com alized report for the risk of prostate cancer recurrence. Dornier MedTech 105 Bayer Healthcare Corporation 303 1155 Roberts Boulevard 400 Morgan Lane Kennesaw, GA 30144 West Haven, CT 06516 www.dornier.com www.bayerusa.com Bayer Healthcare Corporation invites you to visit our booth where our medical representatives can discuss our full range of healthcare products including VIADUR™ (leuprolide acetate 34 implant), Bayer Oncology and NEXAVAR (sorafenib) tablets.

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Company Booth No. Company Booth No. EDAP-TMS 411 We deliver broad, differentiated products including PK™ Technology, the best-in-class tissue management platforms that 4 rue du Dauphine transform endoscopic, open and laparoscopic procedures; and 69120 Vaulx-en-Velin, France advanced Invisio® Digital Technology that dramatically improves www.edap-tms.com visualization. EDAP, headquartered in Lyon, France, is the global leader of medical devices based on High Intensity Focused Ultrasound HealthTronics, Inc. 206 (HIFU). The Company is entirely dedicated to HIFU technology. 1301 Capital of Texas Highway, Suite 200B Conclusive results from clinical studies carried out since 1993 Austin, TX 78746 show that today EDAP is the most advanced company in thera- www.healthtronics.com peutic focused ultrasound. The Ablatherm® is the first HIFU device to have obtained the CE mark for treatment of localized HealthTronics is a urological products and services company that prostate cancer. offers a comprehensive range of diagnostic and therapeutic solutions to physicians, hospitals, surgery centers and clinics. Endocare, Inc. 410 HealthTronics offers the latest technology in lithotripsy services and prostate therapy services. Its product portfolio includes lithotripters, 201 Technologly Drive intra-operative imaging systems, surgical lasers for treatment of Irvine, CA 92618 BPH, urology imaging tables and anatomical pathology services. www.endocare.com Endocare, Inc. is a medical device company focused on devel- Interstitial Cystitis Association 412 oping urological health care technologies with the potential to 110 North Washington Street, Suite 340 dramatically improve men’s health and quality of life. The com- Rockville, MD 20850 pany has concentrated on treatments for prostate cancer. www.ichelp.org Endocare’s mission is extending life everyday. Founded by Dr. Vicki Ratner in 1984 the ICA is dedicated to pro- Esprit Pharma, Inc. 103/202 viding comprehensive, current information on interstitial cystitis (IC); supporting IC patients, families, & friends; educating the Two Tower Center Boulevard medical community and public about IC; advocating for research East Brunswick, NJ 08816 funding and patients’ rights; and promoting & providing www.espritpharma.com research funding for treatments and a cure for IC. Esprit Pharma is a forward thinking company committed to improving patient wellness within the genitourinary and Intuitive Surgical 402 women’s healthcare fields. Lead drugs include Sanctura®, a 1266 Kifer Road, Building 101 uniquely structured therapy for overactive bladder, ProQuin®XR, Sunnyvale, CA 94086 a novel pro-longed release quinolone for the treatment of www.intuitivesurgical.com uncomplicated urinary tract infections, and Estrasorb®, a patented formulation of topically applied lotion for the treatment of Intuitive Surgical, Inc. is shaping the future of urologic oncology moderate-to-severe vasomotor symptoms. surgery with the da Vinci® Prostatectomy (dVP). dVP represents the fastest growing treatment for prostate cancer today and GE Health Care 408 leverages the da Vinci Surgical System’s state-of-the-art technology, including high resolution 3D vision, proprietary EndoWrist® 384 Wright Brothers Drive instrumentation, Intuitive Motion and 4th arm. Salt Lake City, UT 84116 www.gehealthcare.com Karl Storz Lithotripsy-America, Inc. 403 GlaxoSmithKline Canada 204 1000 Cobb Place Boulevard, Building 400, Suite 450 Kennesaw, GA 30144 8455 Transcanadienne www.karlstorz.com St. Laurent, QE H4S 1Z1 Canada www.gsk.ca The Storz MODULITH® SLX-F2 is a one-of-a-kind lithotripter as well as a diagnostic and therapeutic workstation. Equipped with Gyrus ACMI 213 patented, electromagnetic shock wave technology, offering 136 Turnpike Road selectable focus as well as in-line ultrasound and X-ray localiza- Southborough, MA 01772 tion capabilities, the F2 provides unparalled reliability and preci- www.GyrusACMI.com sion in treatment. With more than 700 various systems operat- ing worldwide, Karl Storz Lithotripsy - America, Inc. provides Gyrus ACMI is uniquely positioned to offer physicians complete nationwide sales and customer support, service technicians and “see & treat” solutions including capital equipment, compre- applications training, plus financing and leasing options. hensive disposables and service plans that support their clinical goals and financial challenges. 35

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ Company Booth No. Company Booth No. Karl Storz Endoscopy-America, Inc 403 Lumenis 506 600 Corporate Pointe 2400 Condensa Street Culver City, CA 90230 Santa Clara, CA 95051 www.karlstorz.com www.lumenis.com An international leader in the field of endoscopy for over 60 Lumenis® Inc. is the global leader in medical and aesthetic years, Karl Storz designs, engineers, and manufactures full lines lasers and light-based technology offering multipurpose laser of instrumentation for minimally invasive adult and pediatric systems used for stones, strictures, tumors and BPH treatment. urology, endourology and laparoscopic urologic procedures. Holmium ablation of the prostate is a simple-to-learn outpatient With our superior product line breadth, innovative craftsmanship procedure. It’s easy to become an expert with this highly effec- and clinical effectiveness, we continue our commitment to tive technique that eliminates traditional complications associat- advancing endoscopic technology. ed with TURP Holmium ablation of the prostate. Patients experience immediate symptom relief, little if any bleeding and may Laborie Medical 111 be released the same day without a catheter. Holmium technol- 185 Allen Brook Lane ogy provides minimum penetration with maximum results. The Williston, VT 05495 superficial penetration of holmium ensures that tissue is effi- www.laborie.com ciently vaporized and eliminates concern about damage to sur- rounding tissue. Holmium ablation is the cost effective solution. Urodynamics in now Wireless! Laborie UDS systems for pelvic Hospitals gain unmatched economic benefits by utilizing the floor dysfunction diagnostics and therapy has made urodynamics multipurpose holmium laser. easier and faster to perform with wireless technology and air- charged catheters. Laborie’s family of products: Delphis™, Maple Leaf Hifu 106 Wireless, 8+ channel Urodynamics system, Triton™ Advanced 1377 Cormorant Road, #203 Wireless UDS system ideal for the higher volume practice- Ancaster, Ontario L9G 4V5 Canada expandable to Video, Aquarius TT™ the premier wireless urody- www.hifu.ca namics system, Urostym™ a comprehensive stimulation/biofeed- back treatment system and i-LIST™- information technology Medispec, Ltd. 407 integration solutions to streamline your data process. 12850 Middlebrook Road, Suite 1 Lakewood Pathology Associates (LPA) 409 Germantown, MD 20874 www.medispec.com 1200 River Avenue, Building 10E Lakewood, NJ 08701 Medispec is a leading supplier of affordable shock wave tech- www.lakewoodpath.com nology to the worldwide medical community. The modular E3000 Lithotripsy System is easy-to-use and highly effective at A full service, national pathology company, LPA provides breaking stones. Medispec’s excellent products and best-in-class anatomical pathology services tailored to the outpatient needs of business solutions give your patients access to quality care Urologists. Our facility is accredited by the College of American while making a sound investment in your future. Pathologists with distinction for exceptional service and quality, consistently turning around pathology reports in 48 –72 hours Medtronic 109 interpreted by experienced, board certified pathologists. 710 Medtronic Parkway Laserscope 310 Minneapolis, MN 55432 www.medtronic.com 3070 Orchard Drive San Jose, CA 95134 Medtronic, the global leader in medical technology, introduces www.laserscope.com the InterStim® II system for urinary control and PROSTIVA™ RF Therapy. Consider InterStim® Therapy, an effective treatment option Liebel Flarsheim 110 for your OAB patients. Choose PROSTIVA® RF Therapy – precise, 2111 East Galbraith Road proven RF technology to treat your patients with symptoms of BPH. Cincinnati, OH 45215 Mentor Corp. 305 www.liebel.com 201 Mentor Drive Liebel Flarsheim manufactures urology imaging systems, includ- Santa Barbara, CA 93777 ing the filmless digital Hydra Vision® DR with optimal geometry, www.mentorcorp.com extended anatomical coverage, and LCD viewing with two 19” color monitors. These LCD color monitors come standard with Mentor is a leading global manufacturer and marketer of inno- Integrated Video Distribution. We offer the Hydra Vision® Plus vative medical devices and disposable products for the diagno- with Digital Photo Spot and film capability. sis, management and treatment of urological disorders to include incontinence, retention, prostate and bladder cancer, stone management and erectile dysfunction. 36

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Company Booth No. Company Booth No. Merck Frosst Canada LTD. 207 Q-Med Scandinavia, Inc. 404 40 Cramer Drive 103 Canegie Center, Suite 301 Nepean, ON K2H 5X5 Canada Princeton, NJ 08540 www.merckfrosst.ca www.q-med.com Novartis Pharmaceuticals — Qualigen, Inc. 406 Oncology Division 108 2042 Corte del Nogal, Suite B 180 Park Avenue Carlsbad, CA 92011 Fordham Park, NJ 07932 www.qualigeninc.com www.novartis.com Qualigen, Inc. develops, manufactures and distributes the Novartis Oncology is dedicated to innovative approaches, practi- FastPack® System which is the first blood testing analyzer cal solutions and valuable medical therapies that satisfy the cur- designed to perform quantitative immunoassay tests right in the rent and emerging needs of patients with cancer and the health physician’s office. Utilizing the FastPack® System, physicians can care professionals who care for them. Come visit our exhibit. obtain on-demand laboratory-quality immunoassay test results for Olympus Surgical America 210 their patients in minutes for PSA, Testosterone, TSH and freeT4. One Corporate Drive Richard Wolf Medical Orangeburg, NY 10962 Instruments Corporation 211 www.olympussurgical.com 353 Corporate Woods Parkway Olympus Surgical America is excited to introduce the following Vernon Hills, IL 60061 new and unique products: EXERA II™ Universal Platform High www.richardwolfusa.com Definition video system with our HD EndoEYE line of video laparoscopes, CYF-V2 Flexible Video Cystoscope, URF-P5 When you see a rock, use “The DOC!” The 6.5 / 8.5 Fr. dual Flexible Ureteroscope, Video Ureteroscope, OES Pro channel ureteroscope with 4 Fr. and 2.4 Fr. insert capacities. If Ureteroscopes, Percutaneous Nephroscope, Resection-in-Saline you can’t get in, use the Ultrathin! The Ultrathin ureteroscope’s Resectoscope, and new Bipolar Laparoscopic forceps. small 6 Fr. tip has a large 4 Fr. capacity. The 6 / 8.8 Fr. “Viper” flexible ureteroscope, featuring dual 270° deflection, will snake Oncura 208 into every area of the kidney. 301 Plymouth Road, Suite 130 sanofi-aventis 203/302 Plymouth Meeting, PA 19462 www.oncura.com 300 Sumerset Corporate Bridgewater, NJ 08807 Pfizer 212 www.sanofi-aventis.com 235 E. 42nd Street The sanofi-aventis Group is the world’s third largest pharmaceu- New York, NY 10017 tical company, ranking number one in Europe. Backed by a www.pfizer.com world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, Acting on Our Committment to Urology. thrombosis, oncology, metabolic diseases, central nervous sys- Prescription Dispensing Labs 205 tem, internal medicine, and vaccines. 19230 Stone Oak Parkway, Suite 200 The sanofi-aventis Group is listed in Paris (EURONEXT: SAN) and San Antonio, TX 78258 in New York (NYSE: SNY). www.pdlabs.net TAP Pharmaceuticals 413 Prescription Dispensing Laboratories, a compounding and 675 North Field Drive research pharmacy, has developed and patented the use of a Lake Forest, IL 60045 calcium channel blocker (i.e., Transdermal Verapamil 15%) for www.tap.com the non-invasive, transdermal treatment of Peyronie’s disease and other fibrotic connective tissue disorders. TAP Pharmaceuticals Inc. is a joint venture of Abbott and Takeda Pharmaceutical Company Limited of Japan. PriCare 113 United Medical Systems 308 Ortho McNeil, Inc., 600 Main #1003 Buffalo, NY 14202 1500 West Park Drive, Suite 390 www.levaquin.com Westborough, MA 01581 www.ums-usa.com Ortho-McNeil, Inc./ Johnson & Johnson, makers of Levaquin, are committed to providing the members of the Northeastern 37 Section of the AUA with outstanding value.

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ Company Booth No. Company Booth No. Urologix 104 ple diffusion delivery for up to 12 months. An implant can be inserted in the body, utilizing a simple in-office procedure. Please 14405 Twenty-First Avenue North visit our booth to see placebo filled versions of the implant. Minneapolis, MN 55447 www.urologix.com Watson Pharma, Inc. 313 Uropath, LLC 309 360 Mt. Kemble Avenue Morristown, NJ 07926 3939 Green Oaks Boulevard Northeast, Suite 100 www.watsonpharm.com Arlington, TX 75063 www.uropathllc.com Watson Pharma, Inc. is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes Valera Pharmaceuticals 405 brand and generic pharmaceutical products. Watson strives to 7 Clarke Drive be a leader in the area of urological disorders with the promo- Canbury, NJ 08512 tion of products for overactive bladder, prostate cancer and www.valerapharma.com testosterone deficiency. Valera Pharmaceuticals is a specialty pharmaceutical company with an expertise in drug delivery. Valera’s technology is based on small, flexible polymer implants that release drugs using sim-

Exhibit Hall Hours Thursday, September 7, 2006 Friday, September 8, 2006 Saturday, September 9, 2006 11:30 a.m.–1:00 p.m. 10:00 a.m.– 3:00 p.m. 9:00 a.m.–12:00 p.m. 5:30–7:00 p.m.

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Exhibitor by booth number Booth No. Company Booth No. Company

102 Astellas Pharma US Inc. 307 American Kidney Stone Management, Ltd. 103/202 Esprit Pharma, Inc. 308 United Medical Systems 104 Urologix 309 Uropath, LLC 105 Dornier MedTech 310 Laserscope 106 Maple Leaf Hifu 311 Abbott Laboratories 107 Cook Urological 312 Boehringer Ingelheim Pharma, Inc. 108 Novartis 313 Watson Pharma, Inc. 109 Medtronic 402 Intuitive Surgical 110 Liebel Flarsheim 403 Karl Storz Lithotripsy-America, Inc., 111 Laborie Medical 403 Karl Storz Endoscopy-America, Inc 112 Dendreon Corporation 404 Q-Med Scandinavia, Inc. 113 PriCare 405 Valera Pharmaceuticals 203/302 sanofi-aventis 406 Qualigen, Inc. 204 GlaxoSmithKline Canada 407 Medispec, Ltd. 205 Prescription Dispensing Labs 408 GE Health Care 206 HealthTronics 409 Lakewood Paathology Associates 207 Merck Frosst Canada LTD. 410 Endocare, Inc. 208 Oncura 411 EDAP-TMS 209 Aureon Laboratories 412 Interstitial Cystitis Association 210 Olympus Surgical America 413 TAP Pharmaceuticals 211 Richard Wolf Medical Instruments Corp. 502 Auxilium Pharmaceuticals, Inc. 212 Pfizer 504 Boston Scientific Corporation 213 Gyrus ACMI 506 Lumenis 303 Bayer Healthcare Corporation 304 American Medical Systems 305 Mentor Corp. 306 DiagnoCure Inc.

You don’t want to miss this! Make sure to complete the raffle tickets included in your registration packet with your name and contact information. Prizes include complimen- tary registration to next year’s Annual Meeting in Rochester or a weekend stay at the Westin Ottawa with Sunday Brunch. Raffle tickets can be turned in at various locations on the exhibit floor and the winners will be announced at the President’s Banquet on Saturday, September 9. You must be present at the banquet to win! 39

REGISTER ON LINE AT WWW.AUANET.ORG/NORTHEASTERN/ Author Disclosures Author Disclosure Presentation #(s) Adamo, Georges None P3, P4 Akhavan, Ardavan None P31 Antebi, Elie None P1, P5 Assimos, Dean Med Rewiew in Urology, Board member or officer, Ixoion Corp., Guest Lecture Boston Scientific, Investigator Badger, William None P22, P23 Bastian, Patrick None 12 Belarmino, James None P50, P51 Benayoun, Serge None 10, P8 Blau, Joel None Guest Lecture Boczko, Judd None 28, 29, 30, P18, P19 Bojani, Naeem None P2, P42 Brock, Gerald None Guest Lecture Cannon, Glenn None 18, 36, P38 Capello, Seth Astra-Zenica, Discussion of Commercial Products which involve 5 off-label or investigational uses Clark, Aaron None P62 Carroll, Peter National Cancer Institute, TAP, Department of Defense, Investor, Guest Lecture Infomedical, Meeting participant and Lecurer Cloutier, Vincent None 26, P17 Conners, William None P39 Corcoran, Anthony None P25 Delongchamps, Nicolas None 1 Elkelini, Mohamed None P30 Emerson, Laurel None P21 Eure, Gregg None Guest Lecture Feifer, Andrew None 27 Ford, Beneranda None P46 Foster, Harris Cetrorelix, Board Member or officer, Boehringer Ingelheim, GSK, Guest Lecture OrthoUrology, Consultant or advisor Fradet, Vincent None 2, 23, P15 Gibbons, Erin None P9 Giramonti, Karla Pfizer 22 Goldfischer, Evan Pf Inc., Other P37 Goldfischer, Evan Astellas Pharma, Consultant P43 Golijanin, Dragan Novadaq Technologies Inc., Toronto, Canada, Grant Support 19, P52, P53 Gomella, Leonard AstraZeneca, TaP, GSK, Consultant, Dendreon, Antigenics, Hexvix, Guest Lecture Scientific study or trial Guru, Khurshid None 14 Hassouna, Magdy None 3 Jacobs, Bruce None P58 Jeldres, Claudio None P12, P13, P14 Johnston, Paul None P49 Karakiewicz, Pierre None P61 Kawashima, Hidenori None P41 Klotz, Laurence None P11 Koch, Michael Focus Surgery, Investigator Guest Lecture Lebeau, Thierry None 11, 24, P59 Leveridge, Mike None P44 Lewinshtein, Daniel None 13, P6, P7, P10 Lillie, David None 6 Matoka, Derek None P40 Mevorach, Robert None P29 Menon, Mani None Guest Lecture 40

NORTHEASTERN SECTION OF THE AUA 2006 ANNUAL MEETING Moyer, Suzanne None 15 Nakatani, Tatsuy Not available at time of publication Guest Lecture Mishisaka, Nobuyasu None Guest Lecture Nogueira, Mark None 31 Onal, Bulent None 21 Palapattu, Ganesh None P34 Patrick, Allan Not available at time of publication Guest Lecture Pautler, Stephen None P48 Pavlov-Shapiro, Sasha None P24 Perrotte, Paul None 9, P55 Porter, Christopher None P16, P56 Ramirez, Alvaro None 8, 25, P54 Regan, James Healthtronics, Investigator Guest Lecture Robb, Sylvia None P47 Roth, Margaret None 33 Roth, Kirk None 34 Shahrour, Khaled None 4, 7 Shapiro, Oleg None P35, P36 Sant, Grannum Vice President Urology, sanofi-aventis Guest Lecture Scardino, Peter Steba Pharmaceuticals, Oncovance, Inc., Merck, Sanofi-aventis, Guest Lecture Consultant or Advisor, NCI, NIH, Prostate Cancer Foundation, Investigator, AstraZeneca, Meeting participant or Lecturer, Penquin Putnam, Inc. Book published, Nature Urology, Editor of journal Shah, Nikhil Pfizer, Inc, Consultant or Advisor Guest Lecture Shiraishi, Taizo None Guest Lecture Singer, Eric None P20, P27 Smaldone, Marc None 16, 35, P26, P32, P33 Spana, Gregory None 32 Stockton, Benjamin None 37 Sugita, Shozo None P45 Sweeney, Danielle None 20, P28 Uzzo, Robert None Guest Lecture Wang, Ming-Hsien None 17 Wu, Guan None P57, P60

Please fill out and return to the registration counter in the 4th floor Foyer at the conclusion of the conference. Only mark those courses you attend. Your CME certificates will be mailed to the address provided below.

LAST NAME FIRST NAME CREDENTIALS

ADDRESS

CITY STATE/PROVINCE ZIP COUNTRY

Accreditation The American Urological Association Education and Research, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Urological Association Education and Research, Inc. takes responsibility for the content, quality and scientiﬁc integrity of this CME activity. CME Credits The American Urological Association Education and Research, Inc. designates this educational activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Thursday 8:30 – 9:30 a.m. Live Surgery 1st Case ____ (1 credit) 9:30 – 10:30 a.m. Intuitive Robotic Video Session ____ (1 credit) 10:30 – 11:30 a.m. Live Surgery 2nd Case ____ (1 credit) 1:00 – 3:00 p.m. State-of-the-Art Lectures 1-4 ____ (2 credits) 3:30 – 5:30 p.m. State-of-the-Art Lectures 5-7 ____ (2 credits)

Thursday Total ____ (7 possible) Friday 8:00 – 9:00 a.m. Podium Session I – Prostate Cancer ____ (.5 credit) 9:00 – 9:30 a.m. Guest Lecture: Lymph Node Dissection in GU Surgery ____ (.5 credit) 9:30 – 10:00 a.m. Open vs. Robotic vs. Laparoscopic Prostatectomy (Point-Counter-Point) ____ (.5 credit) 9:30 – 10:30 a.m. Poster Session I – Prostate Cancer ____ (1 credit) 10:00 – 11:00 a.m. Poster Session II – Laparoscopy, Infertility & Stones ____ (1 credit) 10:30 – 11:30 a.m. Podium Session II – Bladder Cancer ____ (1 credit) 11:30 – 12:00 p.m. Guest Lecture: Superﬁcial Bladder Cancer ____ (.5 credit) 1:00 – 2:00 p.m. Podium Session III – Pediatrics ____ (1 credit) 2:00 – 2:30 p.m. Guest Lecture: Current Concepts in the Management ____ (.5 credit) of Posterior Urethral Valves 3:00 – 4:00 p.m. Poster Session III – Pediatrics, Female Urology, Basic and General Urology ____ (1 credit) 3:00 – 3:30 p.m. Stump the Professor ____ (.5 credit) 3:30 – 4:00 p.m. Podium Session IV – Prostate Cancer Recurrence/Biopsies ____ (.5 credit) 4:00 – 4:30 p.m. Guest Lecture: Prostate Cancer ____ (.5 credit)

Friday Total ____ (7.25 possible) Saturday 8:00 – 9:00 a.m. Podium Session V – Laparoscopy ____ (1 credit) 9:00 – 10:00 a.m. Poster Session IV – Other Cancer ____ (1 credit) 9:00 – 9:30 a.m. Slotkin Lecture ____ (.5 credit) 10:00 – 10:30 a.m. Podium Session VI – Stones ____ (.5 credit) 10:30 – 11:00 a.m. Guest Lecture: Surgical Management ____ (.5 credit) of Patients with Complex Nephrolithiasis 11:00 – 11:30 a.m. Guest Lecture: Interstitial Cystitis – Update on Pathophysiology and Treatment ____ (.5 credit)

Saturday Total ____ (3.5 possible)

OVERALL TOTAL HOURS ____ (Total Possible Hours 17.75) Astellas Prescribing Info Cover 3 Astellas Safety Info Verbidge Cover 4